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Abstract 
Prostate biopsy is the clinical standard for cancer diagnosis and is typically performed 
under two-dimensional (2D) transrectal ultrasound (TRUS) for needle guidance.  
Unfortunately, most early stage prostate cancers are not visible on ultrasound and the 
procedure suffers from high false negative rates due to the lack of visible targets.  Fusion 
of pre-biopsy MRI to 3D TRUS for targeted biopsy could improve cancer detection rates 
and volume of tumor sampled.  In MRI-TRUS fusion biopsy systems, patient or prostate 
motion during the procedure causes misalignments in the MR targets mapped to the live 
2D TRUS images, limiting the targeting accuracy of the biopsy system.  
In order to sample smallest clinically significant tumours of 0.5 cm3 with 95% 
confidence, the root mean square (RMS) error of the biopsy system needs to be <2.5 mm.  
In addition to intermittent prostate motion during the procedure, prostate deformation due 
to needle insertion and biopsy gun firing is a potential source of error that limits needle 
targeting accuracy.  Using non-rigid registration of 2D TRUS images, we quantified the 
deformation that occurs during the needle insertion and the biopsy gun firing and showed 
that the tissue deformation was such that throughout the length of the needle axis, 
spherical tumours with radius 2.1 mm or more can be sampled with 95% confidence, 
under the assumption of zero error elsewhere in the biopsy system. 
The target misalignments due to intermittent prostate motion during the procedure 
can be compensated by registering the live 2D TRUS images acquired during the biopsy 
procedure to the pre-acquired baseline 3D TRUS image.  The registration must be 
performed both accurately and quickly in order to be useful during the clinical procedure.  
We developed an intensity-based 2D-3D rigid registration algorithm and validated it by 
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calculating the target registration error (TRE) using manually identified fiducials within 
the prostate.  We discuss two different approaches that can be used to improve the 
robustness of this registration to meet the clinical requirements.  Firstly, we evaluated the 
impact of intra-procedural 3D TRUS imaging on motion compensation accuracy since 
the limited anatomical context available in live 2D TRUS images could limit the 
robustness of the 2D-3D registration.  The results indicated that TRE improved when 
intra-procedural 3D TRUS images were used in registration, with larger improvements in 
the base and apex regions as compared with the mid-gland region.  Secondly, we 
developed and evaluated a registration algorithm whose optimization is based on learned 
prostate motion characteristics.  Compared to our initial approach, the updated 
optimization improved the robustness during 2D-3D registration by reducing the number 
of registrations with a TRE > 5 mm from 9.2% to 1.2% with an overall RMS TRE of 2.3 
mm.  
The methods developed in this work were intended to improve the needle 
targeting accuracy of 3D TRUS-guided biopsy systems.  The successful integration of the 
techniques into current 3D TRUS-guided systems could improve the overall cancer 
detection rate during the biopsy and help to achieve earlier diagnosis and fewer repeat 
biopsy procedures in prostate cancer diagnosis. 
 
Keywords: prostate biopsy, three-dimensional ultrasound, transrectal ultrasound, 
prostate motion, motion compensation, image registration, 2D-3D registration, 
registration optimization 
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Chapter 1. 
Introduction 
Prostate biopsy is the clinical standard for prostate cancer diagnosis, which is a procedure 
usually performed under two-dimensional (2D) transrectal ultrasound (TRUS) guidance.  
Unfortunately, most early stage prostate cancers are not visible on ultrasound, so the 
procedure is routinely performed in a systematic, but ultimately random fashion, where 
biopsy cores are collected following a standard sextant plan with the aim of sampling any 
tumors that are occult on ultrasound [1].  The procedure suffers from a false negative rate 
as high as 30% due to the lack of visible targets [2].  Prostate magnetic resonance 
imaging (MRI) is more sensitive to detection of small lesions and its use for pre-biopsy 
target identification is rapidly growing [3-5].  With the objective of improving the cancer 
detection rate during biopsy, systems have been developed to perform a targeted biopsy 
by fusing pre-biopsy MRI with 3D TRUS [6-11].  In many such systems, prior to 
performing biopsy, suspicious lesions delineated as targets in a pre-biopsy MR image are 
mapped to the static baseline 3D TRUS image acquired at the beginning of the biopsy 
session [12-15].  Biopsy is subsequently performed, targeting each suspicious lesion 
using the live 2D TRUS images acquired while tracking the ultrasound probe position 
and orientation relative to the baseline 3D TRUS image. 
Prostate biopsy is an outpatient procedure that is performed when the patient is 
awake in the lateral decubitus position under local anaesthesia.  We have observed that 
patient discomfort can lead to intermittent prostate motion/displacement during the 
procedure.  TRUS probe pressure is another source of prostate motion, when the 
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physician maneuvers the probe to reach different regions within the prostate; although the 
prostate is attached to the surrounding tissue, it can move as a unit within the pelvis in 
response to probe pressure at different prostate locations [16]. The variability in applied 
TRUS probe pressure could also deform the prostate, particularly in the posterior region.  
In a targeted approach to biopsy where suspicious locations for cancer need to be 
sampled, intermittent prostate motion during the procedure could limit accuracy in 
maintaining the correspondence between live TRUS images and the targets defined in the 
baseline 3D TRUS image.  Identification of the errors due to prostate motion and the 
development of accurate and fast registration methods to compensate for patient and 
prostate motion during the procedure are therefore helpful to improve needle targeting 
accuracy of 3D TRUS-guided biopsy systems. 
The focus of this thesis is to quantify and compensate for the errors due to patient 
and prostate motion during biopsy in the mechanically assisted 3D TRUS-guided biopsy 
system [8] previously developed in our lab.   This would help to detect clinically 
significant tumours at an early stage using the emerging MR-targeted, 3D TRUS-guided 
approach to performing biopsy and could impact the overall prostate cancer detection rate 
from biopsy, leading to fewer biopsy sessions, earlier diagnosis, and appropriate 
treatment selection.  The remainder of the chapter describes the current status in prostate 
cancer prevalence, the available diagnostic methods, 3D-guided biopsy systems and how 
image-based registration could help improve their clinical outcomes in practice with 
hypothesis and specific objectives of the thesis. 
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1.1 Prostate cancer and its prevalence 
Prostate cancer is the most commonly diagnosed non-skin cancer among Canadian men 
contributing to 25% (~24, 000) of all estimated new cancer cases in 2013 [17].   It is also 
reported to be the third largest contributor to estimated cancer deaths among Canadian 
men in 2013, representing 10% of all deaths [17].  Approximately 1 in 7 men will be 
diagnosed with prostate cancer during his lifetime and 1 in 37 will die of this disease.  
Prostate cancer incidence increases with age, with 34% of men in their 50s and 70% of 
the men at the age 80 showing histologic evidence of prostate cancer [18].  Prostate 
cancer exhibits a wide variation of natural history, with the existence of clinically 
indolent tumours in some men and aggressive, metastatic, lethal tumours with 
considerable morbidity in others.  Therefore, the ability to differentiate between indolent 
and aggressive disease during the diagnosis is paramount for successful prostate cancer 
management in the population. 
 
Figure 1.1: (a) Anatomical position of the prostate relative to the neighboring organs in a sagittal view. (b) 
Primary anatomic regions of the prostate in a sagittal view. 
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The prostate in a healthy adult male is a walnut sized organ, approximately 20 
cm3 in volume, sitting on the pelvic floor, surrounding the urethra, and proximal to the 
bladder neck (Figure 1.1(a)).  The base, the mid-gland and the apex constitute the three 
primary anatomic regions of the prostate (Figure 1.1(b)).  The superior region of the 
prostate proximal to the bladder neck is identified as the base, while the inferior region 
proximal to the urogenital diaphragm is identified as the apex.  The prostate has also been 
divided anatomically into four different lobes: (1) anterior lobe, (2) posterior lobe, (3) 
lateral lobes, and (4) median lobe. McNeal [19-21] proposed a zonal model, which is 
widely used in pathology, to describe prostate glandular anatomy, dividing the prostate 
into three distinct zones: (1) central zone; (2) peripheral zone; and (3) transition zone 
(Figure 1.2). The central zone (CZ) is a wedge-shaped volume containing about 25% of 
the glandular tissue of the prostate, in the region between the bladder neck to 
verumontanum.  The peripheral zone (PZ) is the largest zone lying distal to the central 
zone containing about 70% of the glandular tissue within the prostate.  The transition 
zone (TZ) comprises 5% to 10% of prostate glandular tissue lying on either side of the 
urethra just above the ejaculatory duct openings.  The anterior fibromuscular stroma (AZ) 
is another portion consisting of approximately one-third of the prostate organ.  It is 
composed of non-glandular tissue [21], although some consider it to be the fourth zone 
[22]. 
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Figure 1.2: Central zone (CZ), peripheral zone (PZ), transition zone (TZ), anterior fibromuscular stroma 
(AZ) constituting the zonal anatomy of the prostate in a sagittal view. 
Most men tend to have some enlargement of the prostate with aging, sometimes 
causing a common urologic condition known as benign prostatic hyperplasia (BPH). This 
enlargement affects primarily the transition zone, occurring above the level of 
verumontanum.  Since the prostate wraps around the urethra, prostate enlargement can 
obstruct the flow of urine.  Therefore, urinary obstructive symptoms such as urinary 
retention, frequent urination and nocturnal voiding are possible with BPH patients. 
However, BPH patients do not show increased risk of developing prostate cancer [23].   
BPH is not the only cause of prostate growth in aging men.  Prostate cancer 
tumours could cause growth and create hard nodules within the prostate.  Prostate cancers 
can be multi focal, and about two thirds are found in the peripheral zone, causing an 
asymmetric growth of the prostate.  Unlike BPH, however, early stage prostate cancers 
are asymptomatic, making timely diagnosis very challenging.  Although current 
understanding of what causes prostate cancer is limited [24], endogenous factors such as 
age, family history and ethnicity have shown association with cancer risk [25]. 
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1.2 Prostate cancer diagnosis 
1.2.1 Digital rectal examination (DRE) 
Early detection of prostate cancer is critical to devise successful treatment methods in 
order to reduce morbidity and mortality.  Since early stage prostate cancer is 
asymptomatic, there are screening tests advocated with the goal of improving diagnostic 
outcomes among the average to high-risk population.  Digital rectal examination (DRE) 
is the first screening method introduced as early as in 1905, in which the physician 
palpates the prostate with a gloved finger inserted into the patient’s rectum.  The 
physician examines for discrete hard nodules, prostate asymmetry and firmness as 
characteristics that are suspicious for cancer. Although this is an easy, inexpensive test, it 
suffers from poor sensitivity with cancer detection rates < 50%, missing most early stage 
tumours [26].   Most cancers were detected at an advanced stage with this method and the 
diagnostic decisions were prone to high inter-examiner variability [27].   
1.2.2 Prostate specific antigen (PSA) test 
The serum level of prostate specific antigen (PSA) in the blood is another screening test 
introduced in the late 1980s.  The probability of cancer increases with concentration of 
PSA in blood, with the most commonly used threshold being 4 ng/ml for prostate cancer 
detection.  Although PSA has high sensitivity for cancer detection, the PSA level in the 
blood can increase due to conditions unrelated to cancer, such as BPH, infection or 
inflammation, resulting in poor specificity of the test [28, 29].  Although the use of PSA 
screening since 1985 has impacted the patterns in cancer incidence and mortality [30], the 
poor sensitivity of screening tests for detecting cancer and the challenges in 
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differentiating between indolent and aggressive disease could potentially result in 
overdiagnosis and overtreatment.  Currently, the American Cancer Society recommends 
that average-risk, asymptomatic men at age 50 to make an informed decision with the 
physician to be screened for prostate cancer [31].    The clinical standard for definitive 
diagnosis of prostate cancer is prostate biopsy.     
1.2.3 Prostate biopsy  
Patients with elevated PSA or abnormal DRE are referred to prostate biopsy. Needle 
biopsy remains the clinical standard for prostate cancer diagnosis, a procedure performed 
with the objective of detecting aggressive tumours that could cause potential harm.  It is 
an outpatient procedure conventionally performed using 2D transrectal ultrasound 
(TRUS) guidance.  It is usually performed when the patient is in left lateral decubitus 
position with local or topical anesthesia. The physician samples tissue locations following 
a sextant template biopsy scheme using a spring-loaded 18-gauge biopsy needle.  Several 
systematic biopsy schemes have been proposed [1, 32, 33] and usually 6-12 biopsy cores 
are taken during the procedure under these schemes.  The tissue samples are then 
processed and examined by urological pathologists in search for any histological 
abnormalities and to assess the severity and extent of the disease.    
Assessing the extent of the disease is a vital component before devising 
appropriate treatment methods.  The most commonly used method to categorize the 
disease extent is the TNM staging system [34].  According to this scheme, cancer is 
classified into four major stages (T1 – T4) evaluating three main areas: (1) primary 
tumour, (2) metastatic disease, and (3) involvement of nearby lymph nodes.  Table 1.1 
shows the diagnostic criteria for classification of the different stages of cancer.  Prostate 
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biopsy results, prostate cancer imaging and manual palpation of the prostate could aid in 
determining the disease stage during diagnosis.  TRUS has been the conventional and 
most widely used imaging modality in examining the extent of hypoechoic regions in the 
prostate  for suspicion of cancer [35].  However, MRI has recently shown promise, with 
improved sensitivity (73-86%) and specificity (77-94%) in determining cancer stage [36, 
37]. 
Table 1.1: TNM staging of prostate cancer 
Stage Criteria 
T1 Tumour at incidental stage, but impalpable and not detectable by imaging 
T2 Locally confined palpable tumour 
     -T2a Tumour exists in half or less than half of one of the two lobes 
     -T2b Tumour exists in more than half of only one lobe 
     -T2c Tumour exists in both the lobes 
T3 Tumour has spread through the prostatic capsule 
T4 Tumour has invaded to other neighboring organs 
 
 
 
In measuring the severity of prostate cancer, the Gleason grading system [38] is 
the most widely accepted and commonly used method.  In this system, the glandular 
pattern of the tumour in biopsy cores is identified and assigned a grade from 1 to 5 at a 
relatively low magnification level.  The scoring is based on the differentiation of prostate 
cancer cells, with 1 the most differentiated and 5 the least differentiated.  Both the 
primary tissue grade – score given to the most prevalent pattern containing the tumour –, 
and the secondary grade –  the score given to the second most prevalent pattern 
containing the tumour – are assessed independently and summed to get the overall 
Gleason score.  Thus, the Gleason score can range from 2 (1+1) to 10 (5+5), with 2 being 
the lowest grade given to insignificant disease and 10 being the highest grade given to 
advanced disease.  A Gleason score of 7 (4 +3) indicates that the patient has the most 
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common glandular pattern with a score 4 and the second most common pattern with a 
score 3.  A Gleason score of 7 (4 + 3) is less desirable than a score of 7 (3 + 4), since the 
most common glandular pattern is less aggressive in the latter. 
Based on the results of PSA, staging and grading, cancer patients can be classified 
into three risk groups [39-41].  According to the classification by D’Amico et al. [41], 
patients with Gleason score 8-10, stage ≥T2c or PSA >20 ng/ml are considered high risk, 
with aggressive tumours and advanced disease.  While these patients are not 
recommended for localized therapy, the typical treatment options are radical 
prostatectomy and external beam radiotherapy.  Patients with Gleason score 7, stage T2b 
or PSA 10.1-20 ng/ml are considered to be intermediate risk.  These patients with organ 
confined disease are amenable to be treated with localized treatment methods such as 
focal laser ablation and high intensity focused ultrasound. On the other hand, the patients 
with Gleason score 2-6, stage T1-T2a, and/or PSA <10 ng/ml are considered to be low 
risk and clinically insignificant. 
The prostate biopsy results play a critical role in differentiating between 
aggressive and indolent disease and in selecting treatment options for tumours that need 
attention.  While underdiagnosis and undertreatment of aggressive cancers could cause 
lethal effects on patients, overdiagnosis and overtreatment could lead to undesirable 
health outcomes like urinary incontinence and erectile dysfunction.  Unfortunately, the 
“blind” approach to systematic prostate biopsy has high false negative rates in the range 
10-30% [32, 42-44], leaving uncertainty in the generated results during its role as the 
diagnostic tool for prostate cancer.  As a consequence, clinicians have to base their 
decisions on evidence that is inconclusive and repeat biopsies might need to be 
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performed to increase the certainty of the diagnosis.  For example, an increasing trend in 
PSA level could lead to repeat biopsy in patients who have already undergone prior 
negative biopsies.  Patients who underwent a second biopsy session have reported cancer 
detection rates of 19%, [45] indicating the limitations of the conventional systematic 
biopsy scheme. In order to improve the cancer detection rates, saturation biopsy schemes 
have been proposed by increasing the number of biopsy cores to the range 15-31 [46-48].  
However, the high probability of these schemes to detect clinically indolent cancers, 
increased cost and morbidity have limited their adaptation as the mainstay approach to 
biopsy in comparison to the sextant approach with 6-12 cores.  In fact, a subsequent 
prospective study [49] reported no significant difference in terms of cancer detection rate 
in saturation and sextant approaches.  
1.3 Prostate cancer imaging 
1.3.1 Ultrasound imaging 
Ultrasound evaluation of the prostate could be achieved via transabdominal, transrectal or 
transperineal access.  TRUS is the most common approach used in prostate examinations 
to detect pathology and calculation of prostate volume [50]. The transrectal approach 
provides better access to peripheral zone tumours in prostate posterior, where 70-80% of 
the prostate cancers arise [51] and  improves the ability to direct needles into regions of 
interest during biopsy procedures. 
A transducer containing transmitting elements, electrodes, and protective face 
generates ultrasound waves [52].  High frequency ultrasound transducers within the range 
5-10 MHz are used for TRUS imaging.  Commercially available TRUS probes are either 
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side-firing or end-firing, with end-firing probes more suitable for image guidance during 
trans-rectal prostate biopsy [53].  Some probes come with enhanced functionality to 
simultaneously acquire dual-orthogonal (transverse and sagittal) planes or full 3D 
imaging.  While the acquisition rate is 10-20 frames per second using single-plane 2D-
TRUS probes, 3D image acquisition could take up to 5 s using enhanced probes.  
Ultrasound waves are reflected as they penetrate through different tissues and 
anatomical structures.  The degree of reflectance depends on the acoustic impedance 
between two layers of tissue.  Structures that reflect most of the ultrasound waves appear 
as bright regions in images while the structures that reflect the least appear as dark 
regions.  Relative to the medium-gray echogenicity of the peripheral zone, structures that 
appear brighter are termed hyperechoic and those that appear darker are termed 
hypoechoic.   The pubic bone and prostatic calcifications are examples of hyperechoic 
anatomical structures that appear bright on ultrasound.  On the other hand, fluid-filled 
structures like seminal vesicles, vas deferens, ejaculatory ducts, cysts, and the gall 
bladder appear hypoechoic in ultrasound.  Figure 1.3 shows examples of the appearance 
of a calcification and a cyst in 2D TRUS images.  The boundaries between zonal 
anatomical structures can often be identified in ultrasound images as hypoechoic linear 
demarcations.  Prostate cancer in the peripheral zone is typically considered to appear as 
hypoechoic on TRUS [54], while transition zone cancers have shown more heterogeneity 
in appearance.  However, elusive nature of cancer appearance in TRUS has posed many 
challenges in using it as an imaging modality to detect suspicious regions for prostate 
cancer [55, 56] and has been reported with low sensitivity (35-91%) and specificity (24-
81%) values in prostate cancer screening [57-61]. 
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Figure 1.3: The appearance of (a) a calcification, and (b) a cyst in a 2D TRUS image. 
With the objective of improving cancer detection using ultrasound imaging 
modality and providing guidance to suspicious target regions during biopsy, several 
enhanced techniques have been investigated.  Color and power Doppler ultrasound 
imaging has been applied to evaluate blood flow and vascularity within the prostate tissue 
[62, 63].  Due to the formation of new vessels in tumours, cancerous tissues tend to 
demonstrate hypervascularity [64].  Contrast-enhanced ultrasound (CEUS) is another 
approach to improve tumour visibility in imaging where encapsulated gas microbubbles 
are injected into the small vessels to improve their ultrasound reflectivity in highly 
vascular regions formed potentially due to cancer [65, 66].  Elastography is another 
ultrasound-based imaging technique that is currently being investigated to detect tumours 
using mechanical properties of tissues.  Since the tissue stiffness properties differ in 
cancerous tissues, elasticity imaging techniques could potentially be used to identify them 
in real time [67].    Although some of these ultrasound-based imaging methods are the 
subject of active research, the benefits of such approaches in improving clinical outcomes 
over systematic biopsy have not yet been proven [68, 69]. 
(a) (b)
  
13 
 
1.3.2 Computed tomography (CT) and nuclear imaging 
Other modalities like CT, positron emission tomography (PET) and single photon 
emission computed tomography (SPECT) have been used to image the prostate.  
However, their use has been primarily focused on radiotherapy planning and prognostic 
evaluation of metastatic disease. CT images are sometimes acquired for the purpose of 
determining the cancer stage when it has spread at a macroscopic level to the perineal 
floor and lymph nodes [70], but are rarely acquired for primary prostate evaluation.  
Similarly, PET and SPECT imaging are used in identification of metastatic spread of 
cancer to the bones. 
1.3.3 MR imaging 
Although moderate staging performance was observed for images obtained from early 
MR scanners [71], with recent improvements in signal-to-noise ratio and image quality 
[72], multi-parametric MR images have shown promise in detecting and localizing 
prostate cancer.   T1-weighted imaging has been demonstrated to be useful in TRUS-
guided biopsy hemorrhage artifact detection, but has limited use in prostate cancer 
imaging due to low contrast.  T2-weighted MR is the most widely used sequence for 
prostate cancer imaging and it can clearly differentiate the prostate zonal anatomy. On 
T2-weighted images, the typical peripheral zone has high-signal intensity, greater than 
nearby structures [73].  In prostate cancer, the loss of normal glandular morphology tends 
to cause regions with low-intensity level.  Benign conditions like BPH typically have a 
nodular appearance on T2-weighted imaging; however, loss of glandular morpohology 
can also cause BPH to appear as a low-intensity signal.  Due to these confounding 
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factors, prostate cancer detection using T2-weighted imaging alone could be challenging 
[74].  However, different functional MR techniques can be used in combination to 
improve the differentiation of cancerous tissue.  
Diffusion-weighted MR imaging is a functional imaging technique in which 
proton diffusion properties in water are used to generate image contrast by quantifying 
the average random motion of hydrogen nuclei within the body.  The apparent diffusion 
coefficient (ADC) quantifies the direction and distance of water molecules due to both 
perfusion and diffusion within the interpulse time of an applied motion-encoding gradient 
in MR that cause proton movements and phase shifts.  Healthy prostate peripheral zone 
tissue contains tubular structures that allow abundant diffusion of water molecules in 
these regions, resulting in high ADC values.  Prostate cancer, in contrast, tends to destroy 
the tubular structures and replace ducts often showing lower ADC values when compared 
with healthy prostate tissue [75, 76].  However, conditions like BPH and prostatitis could 
result in lower ADC values, which could limit the ability to make a definitive diagnosis 
using this information alone [77, 78]. 
 
Figure 1.4: Multiparametric MR images of the prostate with suspicious region for cancer indicated by the 
yellow arrow: (a) T2-weighted image showing a region with hypo intensity. (b) DCE image not showing 
any contrast for this patient in the suspicious area. (c) ADC map showing a region of hypointensity. 
(a) (b) (c)
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Dynamic contrast-enhanced (DCE) MR imaging is another functional imaging 
method to aid in the detection of cancerous regions by noninvasively examining tumor 
angiogenesis.  It consists of a series of T1-weighted images acquired successively after 
injection of a gadolinium contrast agent to evaluate tumour vascular function.  Since 
prostate cancer tumours are highly vascular, a comparison of pre- and post-gadolinium 
images could be used to identify regions suspicious for prostate cancer [79].  When 
compared with healthy tissue, prostate cancer tends to show rapid wash-in and wash-out 
with the contrast agent injection [80].  Magnetic resonance spectroscopy imaging (MRSI) 
[81], MR elastography [82] and sodium imaging [83] are some other emerging 
techniques that have the potential to aid prostate cancer detection via imaging. 
Developing mechanisms for prostate cancer detection and localization is a non-
trivial task considering the biological and pathological complexity of the disease.  
Although different MR imaging sequences have their strengths and limitations, 
combination of different techniques could help to mitigate the limitations of individual 
sequences and help improve the accuracy in making a definitive diagnosis.  Figure 1.4 
shows the appearance of a suspicious cancer region of a patient in T2-weighted, DCE and 
DWI images.  The European Society of Urogenital Radiology (ESUR) has recently 
published a report [84] providing guidelines for MRI of prostate cancer based on 
published evidence and expert opinion. This report recommends the use of a combination 
of high-resolution T2-weighted images and at least two functional MRI techniques when 
detecting cancer with a multiparametric MRI examination. The guidelines also include a 
structured scoring system (Prostate Imaging and Reporting Data System [PI-RADS]) for 
classification and reporting of tumours during the diagnosis.  While the clinical protocols 
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using multiparametric MRI for prostate cancer are becoming standardized, currently 
active research is focused on investigation of MR to histopathology correlation to further 
improve the detection of cancer using in vivo imaging [85-88].  Although currently 
reported sensitivity (73-86%) and specificity (77-94%) results [89-91] for prostate cancer 
detection in MR imaging does not permit replacement of needle biopsy as the clinical 
standard of diagnosis, multi-parametric MR has the potential utility in guiding biopsy 
towards target regions and subsequently could be used in conjunction with biopsy results 
to make informative assessment during staging and grading of cancer.  Detecting cancer 
using in vivo imaging is also beneficial in contouring tumours for localized treatment of 
intermediate-risk prostate cancer. 
1.4 3D-guided prostate biopsy systems 
While the standard sextant approach to prostate biopsy under 2D TRUS-guidance usually 
lacks visible tumour targets, multi-parametric MRI has shown promise in non-invasive 
detection of cancer.  The addition of the MR-detected cancer suspicious regions as targets 
during biopsy could impact and improve the limited sensitivity and specificity of the 
conventional sextant template schemes.  Aligning the biopsy needle trajectories with the 
regions identified in MR requires accurate localization of target locations within the 3D 
anatomy of the prostate.  In order to achieve this objective, the physician could initially 
identify the target locations in MR and then mentally map those locations into the space 
of intra-procedural TRUS imaging for targeting.   Such an approach to performing biopsy 
with cognitive MR-TRUS fusion can be implemented with existing conventional 2D 
TRUS-guided biopsy systems, eliminating the need for the development and integration 
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of additional hardware and/or software components [92].  However, previous studies [15, 
93, 94] have not shown convincing results in terms of improvement in cancer detection 
rates with this approach in comparison to random systematic biopsy.  In addition, a 
cognitive fusion of images of two modalities is, in principle, operator dependent and 
needle targeting accuracy is likely to be correlated with the 3D cognitive spatial skills and 
experience level of the physician with this task.  Moreover, rotational symmetry and the 
limited discrete anatomical landmarks of the prostate available in 2D TRUS images could 
pose challenges in accurate localization of the target locations in 3D.  Thus, the 
anatomical and spatial context achieved with conventional 2D TRUS guidance alone 
might not yield the desired level of accuracy to guide needles to successfully sample 
tissue from target locations.     
With the objective of improving needle targeting accuracy during biopsy, systems 
[6, 8, 95, 96] have been developed to provide 3D guidance during biopsy.  In addition to 
providing a richer 3D context within which to guide biopsy needle insertion, these 
systems can record and archive biopsy locations in 3D.  These archived locations could 
assist in determining the biopsy target locations if repeat biopsies are required either to 
avoid targeting previously sampled locations or to take a sample closer to a previously 
biopsied location.  MR-identified target locations have been mapped to the intra-
procedural imaging space using two major approaches in the emerging 3D-guided biopsy 
systems: (1) direct MR-guided biopsy systems, and (2) MR-TRUS fusion biopsy systems. 
1.4.1 Direct MR-guided biopsy systems 
There are multiple systems [97] developed that are capable of acquiring MR images 
directly during the procedure for guidance and recording of biopsy locations in 3D.  In 
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these systems, the patient usually lies in the prone position and the needles are inserted 
via either transrectal or transperineal access.  Some of the systems have been designed to 
perform the MR-guided biopsy in an open bore [98-100], while some others perform the 
biopsy in a closed bore [95, 101, 102].  Although open bore systems have less confined 
space during needle manipulation, the image quality is poor due to the use of low field 
magnets.  On the other hand, although closed-bore MR scanners can generate superior 
image quality for better guidance, the confined space inside the bore could pose 
challenges in tool design and manipulation.  During the typical workflow in these 
systems, suspicious target delineation is performed using a previously acquired 
diagnostic MR image prior to the procedure, and identified locations are mapped to the 
intra-procedural imaging space and verified using serial MR scans acquired immediately 
prior to needle placement.  Ultrasound images are not acquired with these systems, and 
the ability to perform the biopsy using a single image modality eliminates complications 
arising when fusing data between two modalities.   Although there has been previously 
published work [103] suggesting improved cancer detection rates with this approach, 
there are several disadvantages limiting its mainstream use as a standard tool for prostate 
cancer diagnosis.  In-bore biopsy procedures have been reported [95] to require more 
than an hour and the patient is usually sedated using general anaesthesia.  Lengthy MR 
scanner time and patient recovery times could impose a huge cost burden on the 
healthcare system, considering the large number of biopsies that needs to be performed in 
a given year.  However, this approach, if proven to have superior targeting accuracy, 
could be amenable to be used in patients who have to undergo multiple repeat biopsies 
sessions due to previously inconclusive biopsy results.  This approach is also valuable to 
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MRI-histology correlative research studies, since an MR image can be acquired with the 
needle in place, allowing for a spatial record of the location of this histologic sample 
within the coordinate system of the MR image. 
1.4.2 MR-TRUS fusion biopsy systems 
Mapping of MR targets to TRUS image space via software-based image fusion is the 
other major approach to 3D-guided biopsy system design. During the clinical workflow 
in these systems, the diagnostic MR image is typically acquired on a day prior to biopsy 
to identify suspicious lesions for cancer.  These targets are then mapped to a baseline 3D 
TRUS image acquired immediately prior to performing the biopsy via MR to 3D-TRUS 
image registration.  The co-registration of the MR and 3D TRUS images needs to be 
performed using a non-rigid transformation to account for the differences in prostate 
deformation due to pressures exerted from the endorectal coil (if used during MR image 
acquisition) or alternatively, the lack of pressure from the body coil, and the manually 
held TRUS probe in the 3D TRUS image acquisition [104, 105].  Live 2D TRUS images 
are typically acquired during the biopsy procedure for real-time image guidance.  The 
correspondence between live 2D TRUS and the baseline 3D TRUS images, into which 
the MRI targets have been mapped, is established via tracking of the TRUS probe’s 
position and orientation in space.  During the procedure, the physician is able to see a 
visualization interface that displays the MRI-identified target locations and relative 
TRUS probe positions and orientations in a 3D context.  Thus, in this approach, tumour 
locations identified from MRI are ultimately targeted with the aid of 3D TRUS image 
guidance.  Hence, the complementary advantages of high soft tissue contrast in MRI and 
real-time, less expensive TRUS imaging, can be exploited to build an economically 
  
20 
 
feasible solution with the aim of improving clinical outcomes of prostate cancer 
diagnosis.  In addition, this enables the prostate biopsy to be still performed as an 
outpatient procedure under local anesthesia, similarly to the conventional 2D TRUS-
guided biopsy procedure. Software tools, that accurately co-register MR targets with the 
baseline 3D TRUS image and intraprocedural TRUS imaging, are thus an essential 
component to the success of this approach.   
Table 1.2: A comparison of some commercially available 3D TRUS-guided biopsy systems. 
System Needle access US probe type 
US probe 
tracking 
Initial 3D US 
image acquisition 
Uronav (In Vivo, 
USA) 
Transrectal 2D TRUS Magnetic tracking Free hand axial 
sweep 
Artemis (Eigen, 
USA) 
Transrectal 2D TRUS Mechanical 
articulated arm 
Rotational sweep  
Urostation 
(Koelis, France) 
Transrectal 3D TRUS Image-based 
tracking 
Panoramic image 
from 3 volume 
acquisitions  
Biopsee (Pi 
Medical, Greece) 
Transperineal Bi-plane TRUS Mechanical 
stepper 
Rotational sweep 
 
 
There are several solutions developed with different hardware and software 
designs to provide image guidance for accurate needle targeting using a MR-TRUS 
fusion approach.  Table 1.2 contains a comparison of some commercially available 
systems showing the approach to image acquisition, tracking and needle placement in the 
different designs.  While some systems are designed to retrofit existing 2D TRUS probes, 
others utilize TRUS probes with enhanced functionality that can simultaneously acquire 
bi-plane of full 3D imaging.  In systems that use conventional 2D TRUS probes, a 3D 
TRUS image is acquired at the beginning of the procedure via rotational or translational 
sweep of the 2D TRUS probe, followed by a reconstruction of the resulting 2D planes to 
obtain a 3D image.  Although enhanced 3D TRUS probes can be more convenient during 
3D image acquisition, the ability to retrofit existing ultrasound systems could be a 
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desirable feature in translating the technology to the widespread clinical use due to the 
potential to leverage the substantial investment in existing equipment.  Accurate and 
reliable TRUS probe tracking is essential to facilitate 3D guidance in these systems.  The 
Uronav system is equipped with electromagnetic (EM) tracking using an external 
magnetic field generator and a freehand TRUS probe [10].  The major disadvantage of 
EM tracking systems is the disruptive influence on tracking arising from potential 
interference from nearby metal devices in the biopsy environment.  The system proposed 
by Bax et al. [8] uses a mechanically articulated arm to track the motion of the probe 
during the procedure.  While this system provides mechanical stabilisation of the probe, it 
also supports locking of all joints during 3D initial image acquisition permitting only 
axial probe rotation.  This design is aimed to minimize prostate motion while the 3D 
image is being acquired, thus minimizing errors during 3D image reconstruction.  The 
system proposed in [6] performs an image-based tracking that completely relies upon the 
information contained within the image acquired using a specialized probe that can 
simultaneously reconstruct a 3D volume.  Eliminating the hardware tracking devices is a 
major advantage of this system to come with a compact design.  However, this system 
requires a specialised 3D TRUS imaging system to acquire rich 3D information for 
tracking purposes.       
1.5 Challenges in 3D-guided biopsy systems 
In order to achieve accurate cancer detection, the 3D-guided biopsy system needs to 
accurately sample tissues from the smallest clinically significant tumours.  There is a 
debate in the clinical community regarding the size of the smallest clinically significant 
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tumour.  Epstein et al. [26] suggested a minimum significant prostate tumour volume of 
0.5 cm3 and we refer to this work when discussing the desired level of accuracy in biopsy 
systems.  Assuming we have correctly identified and delineated tumours on MR imaging, 
there are several potential sources of error that limit 3D-guided biopsy systems in 
achieving a level of accuracy that allows for needle targeting with high confidence: (1) 
MR-TRUS co-registration errors, (2) tracking errors in the system, (3) imaging and 
calibration errors, and (4) errors due to patient and prostate motion/displacement during 
the procedure.  Quantification and minimization of these errors are essential to improving 
the needle targeting accuracy in 3D biopsy systems.  The errors due to sources (1)-(3) 
have been previously quantified and mitigated [8, 105] in the context of the 
mechanically-assisted 3D TRUS-guided biopsy system described in [8].  
Prostate motion/deformation can cause target misalignment during 3D TRUS-
guided biopsy [106].  Since the patient is awake and under local anesthesia, he can move 
due to discomfort during procedure, which is approximately 15 minutes in duration.  The 
TRUS probe pressure applied while the physician navigates the probe to different regions 
of the prostate is another potential cause of prostate motion.  The needle insertion and 
biopsy gun firing procedure could also cause some additional motion.  These motions 
during the procedure can disrupt the correspondence between live 2D TRUS images and 
the targets defined in the coordinate system of the baseline 3D TRUS image, causing 
target misalignments and needle targeting errors.  Studying prostate motion during biopsy 
and finding methods for motion compensation is critical to improving the needle 
targeting accuracy of 3D TRUS-guided biopsy systems. 
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Recent clinical studies [12, 14, 107, 108] comparing 3D versus 2D systematic 
TRUS-guided biopsies have demonstrated evidence suggesting that prostate cancer 
detection rates improve with a 3D-guided approach.  However, evidence from previous 
work [109] analysing prostate motion during biopsy suggests that misalignments due to 
motion can cause substantial errors > 5 mm relative to the clinically significant tumour 
sizes reported in the literature [26, 110].  Therefore, improving needle targeting accuracy 
of biopsy systems could help to further improve cancer detection rates of the 3D TRUS 
guided approach and strengthen the confidence in diagnosing low to intermediate risk 
cancer.   Automatic localization of corresponding anatomical landmarks within the 
anatomy is one potential approach to track motion during biopsy.  Surface-based 
registration algorithms are an example where the segmentation of the prostate boundary 
can be used to achieve correspondence.  While this approach relies upon an accurate, 
automatic segmentation algorithm of the prostate, developing such an algorithm that is 
sufficiently robust can be a challenging task in ultrasound images. Therefore, using the 
image intensity information could lead to more robust image registration solutions and 
simplify the workflow by eliminating the need for prostate segmentation. Development 
and successful clinical translation of rapid image intensity-based registration methods to 
compensate for misalignments due to prostate motion is an indispensable step towards 
improving targeting accuracy to enable sampling of clinically significant tumours during 
prostate biopsy.          
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1.6 Image-based registration techniques 
Image registration is the process of transforming multiple images to spatially align them 
in a single coordinate system.  In image-based registration, the alignment is achieved 
using the information in image signal intensities.  A quantitative measure that reflects the 
desirable properties of a good alignment is defined as the objective function, and can 
comprise of an image similarity metric and a regularization term.  For rigid registration 
applications, the objective function is typically the image similarity metric.  One image is 
transformed, interpolated and compared with the other image to calculate the image-
similarity metric. In a rigid, affine or non-rigid transformation space, optimization 
techniques are utilised to find the optimum metric value in an efficient manner.  Thus, the 
registration framework constitutes of multiple components: (1) image similarity metric, 
(2) optimization technique, (3) transformation (e.g., rigid, affine or non-rigid), and (4) 
interpolator. These components need to be specified in developing the image-registration 
technique. 
Live 2D TRUS images acquired during the procedure need to be co-registered 
with the baseline 3D TRUS image acquired at the beginning of the procedure to 
compensate for motion during the biopsy session.  The development of accurate and fast 
2D-3D registration methods could be challenging due to the limited information available 
in the live 2D TRUS image.   In solving uni-modality registration problems [10], the 
sum-of-squared difference (SSD) and normalized cross-correlation (NCC) could be 
suitable image similarity metrics.  While SSD assumes the same level of image intensity 
at homologous pixels in the two images, NCC tolerates a linear relationship in intensities. 
Therefore, NCC is invariant to the changes in intensity scaling and shift.  These metrics 
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can be inherently parallelized to achieve high-speed implementations to be useful for 
clinical application.  The capture range of the metric is another important consideration 
when selecting a useful metric.  If the metric has a wide capture range within the 
transformation space, large misalignments can be compensated using local optimizers to 
successfully converge at the desired solutions. 
Since brute-force searching of the transformation space is intractable due to 
registration time requirements, the optimization technique is an essential component of 
the registration algorithm to traverse the transformation space in an efficient manner.  
While local optimization techniques are widely used in registration problems that have 
convex, quasi-convex or monotonic objective function landscapes [111], some methods 
in the literature [112, 113] have investigated  the development of global optimization 
techniques to improve registration accuracy and robustness.  Multi-start [114], simulated 
annealing [115], particle swarm [116], genetic [117] approaches have been used in 
registration problems with the objective of improving robustness.  However, this could 
lead to an increase in computation times due to the increase in the number of image 
similarity metric evaluations and slower convergence properties.  Efficient 
implementation of optimization algorithms using graphics processing units (GPU) [113] 
and development of algorithms with improved convergence properties [118] could be 
helpful in adopting such algorithms for applications that require rapid registration. 
The properties of some optimization techniques can be more desirable in 
achieving high speed performance in principle. Multiple local optimization techniques 
(e.g., Newton’s method, quasi-Newton method, conjugate gradient method, Powell’s 
method) developed over the years are derived from a quadratic model and have quadratic 
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convergence properties.  These methods assume and approximate second order 
characteristics of the function within its local neighborhood and are capable of finding 
the optimum of the function in a finite number of function/derivative evaluations given a 
reasonable satisfaction of the quadratic model assumption.  This is a useful property that 
aids fast convergence when optimizing a multi-dimensional function in image 
registration.  Techniques that rely on first order properties of the function (e.g., gradient 
descent/steepest descent [119, 120]), on the other hand, have linear convergence 
properties.  There is another classification of optimization methods based on whether the 
calculation of the objective function’s derivative is required.  Some optimization methods 
(e.g., conjugate gradient method, Newton’s method) explicitly calculate the derivative of 
the objective function, while some others (e.g., Powell’s method [121], CMA-ES method 
[122]) are derivative-free and the optimization is achieved using only function 
evaluations.  Derivative-free methods can be useful if the explicit calculation of the 
function derivative is either time consuming or not straightforward.  
1.7 Image registration accuracy required for the clinical application 
The work in this thesis is focused on the errors due to prostate motion that limit the 
biopsy system in achieving the desired targeting accuracy, but had not been previously 
quantified and mitigated from the potential sources of error that we have enumerated in 
section 1.5.  Given that the suspicious tumour locations have been identified in the 
baseline 3D TRUS image, errors due to intermittent patient and prostate 
motion/displacement during the procedure and due to prostate deformation during the 
needle insertion and the biopsy-gun firing could challenge the accurate targeting of those 
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locations using a 3D TRUS-guided biopsy system.  On the other hand, there is evidence 
suggesting that tumours > 0.5 cm3 are clinically significant [26, 110]; such tumours have 
a radius of 5 mm under the spherical assumption. In order to accurately target a 5 mm 
radius spherical tumour with 95% probability, the root mean square (RMS) error of the 
biopsy system should be ≤ 2.5 mm.  
1.8 Hypothesis 
The central hypothesis is that image-based 2D-3D registration of TRUS images can 
correct for intermittent prostate displacement during the biopsy procedure, with an RMS 
target registration error (TRE) ≤ 2.5 mm. 
1.9 Objectives 
To test the central hypothesis, the four major objectives of this thesis work are: 
I. To quantify the prostate motion and deformation due to needle insertion and 
biopsy-gun firing procedure and calculate the 95% prediction interval around the 
tissue deformation and compare this deformation in handheld and mechanically-
assisted systems. 
II. To (a) develop a 2D-3D registration technique with sufficient accuracy and speed 
for prostate motion compensation during biopsy, and (b) validate this registration 
method retrospectively using live 2D TRUS images and baseline 3D TRUS 
images acquired during human clinical biopsy procedures using a mechanically-
assisted 3D TRUS-guided biopsy system [8].  
III. To (a) evaluate the utility of intra-procedural 3D TRUS images in guiding 
registration during motion compensation to robust solutions, (b) identify the 
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anatomical regions that benefit the most from such additional intra-procedural 3D 
information, and (c) test whether a robust rigid registration is sufficient to achieve 
clinically desired level of accuracy.    
IV. To (a) improve the robustness of registration optimization using learned 
characteristics from observed prostate motion data, (b) measure the major patterns 
of prostate motion during biopsy, and (c) modify Powell’s direction set method 
initialization to incorporate learned motion characteristics. 
1.10 Thesis outline 
1.10.1 Chapter 2 - Quantification of prostate deformation due to needle 
insertion during TRUS-guided biopsy: Comparison of hand-held and 
mechanically stabilized systems 
In this chapter, we describe our work to quantify the deformation that occurs during the 
needle insertion and the biopsy-gun firing procedure using non-rigid registration of 2D 
TRUS images acquired during human clinical biopsy procedures.  We calculated the 
spatially varying 95% confidence interval on the prostate tissue motion and analysed this 
motion both as a function of distance to the biopsy needle and as a function of distance to 
the lower piercing point of the prostate. The former is relevant because biopsy targets lie 
along the needle axis, and the latter is of particular importance due to the reported high 
concentration of prostate cancer in the peripheral zone, a substantial portion of which lies 
on the posterior side of the prostate where biopsy needles enter the prostate after 
penetrating the rectal wall during transrectal biopsy.  
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The results showed that for both systems, the tissue deformation is such that 
throughout the length of the needle axis, including regions proximal to the lower piercing 
point, spherical tumours with radius 2.1 mm or more can be sampled with 95% 
confidence, under the assumption of zero error elsewhere in the biopsy system. More 
deformation was observed in the direction orthogonal to the needle axis, compared to the 
direction parallel to the needle axis; this is of particular importance given the long, 
narrow shape of the biopsy core. We measured lateral tissue motion proximal to the 
needle axis of not more than 1.5 mm, with 95% confidence. We observed a statistically 
significant, but clinically insignificant maximum difference of 0.38 mm in the 
deformation resulting from the hand held and mechanically assisted systems along the 
needle axis, and the mechanical system resulted in a lower relative increase in 
deformation proximal to the needle axis during needle insertion, as well as lower 
variability of deformation during biopsy gun firing. 
1.10.2 Chapter 3 - 2D-3D rigid registration to compensate for prostate 
motion during 3D TRUS-guided biopsy 
The error due to needle insertion and biopsy gun-firing procedure, described in Chapter 
2, occurs during a very short period of time and is challenging to compensate.  
Intermittent patient and prostate motion cause larger misalignments [109] challenging the 
needle targeting accuracy to meet this requirement. To compensate for this motion, we 
implemented and tested an intensity-based 2D-3D rigid registration algorithm optimizing 
the NCC using Powell’s method.  The 2D TRUS images acquired during the procedure 
prior to biopsy gun firing were registered to the baseline 3D TRUS image acquired at the 
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beginning of the procedure.  The accuracy was measured by calculating the TRE using 
manually identified fiducial markers (henceforth fiducials) within the prostate for eight 
patients. These fiducials were used for validation only and were not provided as inputs to 
the registration algorithm.  We also measured the accuracy when the registrations were 
performed continuously throughout the biopsy procedure by acquiring and registering 
live 2D TRUS images every second.  This measured the improvement in accuracy 
resulting from performing the registration continuously compensating for motion during 
the procedure.  To further validate the method using a more challenging data set from 10 
patients, registrations were performed using 3D TRUS images acquired by intentionally 
exerting different levels of ultrasound probe pressures in order to measure the 
performance of our algorithm when the prostate tissue was intentionally deformed.  In 
this data set, biopsy scenarios were simulated by extracting 2D frames from the 3D 
TRUS images and registering them to the baseline 3D image.  A GPU-based 
implementation was used to improve the registration speed. We also studied the 
correlation between NCC and TREs.   
With the GPU based implementation, the registrations were performed with a 
mean time of 1.1 s.  The TRE values before, during and after registration showed a weak 
correlation (r2 = 0.23) with the similarity metric.  However, we measured a generally 
convex shape of the metric around the ground truth registration, which may explain the 
rapid convergence of our algorithm to accurate results.  The RMS TRE of registrations 
performed prior to biopsy gun firing was found to be 1.87 ± 0.81 mm.  This was an 
improvement over 4.75 ± 2.62 mm before registration.  When the registrations were 
performed every second during the biopsy, the RMS TRE was reduced to 1.63 ± 0.51 
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mm.  However, for a 3D data set acquired under a more controlled range of probe 
pressures intended to test the robustness of the algorithm, the RMS TRE was found to be 
3.18 ± 1.6 mm. This was an improvement from 6.89 ± 4.1 mm before registration.  
Assuming this TRE and the TRE resulting from tissue displacement during needle 
insertion (Chapter 2) are independent, they can be added in quadrature to determine an 
overall TRE that can be compared against the 2.5 mm TRE threshold in the central 
hypothesis.  From Chapter 2, we measured an RMS TRE of 1.1 mm; adding (in 
quadrature) a further TRE of 2.3 mm to this 1.1 mm yields a total of 2.5 mm.  Thus, for 
the central hypothesis of this work to be confirmed, an image registration algorithm with 
RMS TRE ≤ 2.3 mm is required. While the results in this chapter showed encouraging 
results in improving the accuracy in needle targeting, the measured 3.18 mm RMS TRE 
suggests that further improvements in accuracy and robustness could be helpful to meet 
the clinical requirements for successful translation of this method.   
1.10.3 Chapter 4 – Evaluating the utility of intra-procedural 3D TRUS 
image information in guiding registration for displacement compensation 
during prostate biopsy. 
The 2D-3D registration for motion compensation described in Chapter 3 can be 
challenging in cases where a single plane 2D TRUS plane does not capture enough 
anatomical context to drive the registration algorithm to the desired solution.  While 2D 
TRUS images are widely used for intra-procedural guidance, some solutions utilize richer 
intra-procedural images such as bi- or multi-planar TRUS or 3D TRUS, acquired by 
specialized probes. In this chapter, the impact of such richer intra-procedural imaging on 
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motion compensation accuracy was measured to evaluate the tradeoff between cost and 
complexity of intra-procedural imaging versus improved motion compensation.  Baseline 
and intra-procedural 3D TRUS images were acquired from 29 patients at standard 
sextant-template biopsy locations. Planes extracted from 3D TRUS images acquired at 
sextant positions were used to simulate 2D and 3D intra-procedural information available 
in different potential clinically-relevant scenarios for co-registration with the baseline 3D 
TRUS image. In practice, intra-procedural 3D information can be acquired either via the 
use of specialized ultrasound probes (e.g., multi-planar or 3D probes) or via axial rotation 
of a tracked 2D TRUS probe. Registration accuracy was evaluated by calculating the 
TRE using manually-identified homologous intrinsic fiducial markers (micro-
calcifications). The TRE was analysed separately at the base, mid-gland and apex regions 
of the prostate. 
The results indicated that TRE improved gradually as the number of intra-
procedural imaging planes used in registration was increased, implying that 3D TRUS 
information assisted the registration algorithm to robustly converge to more accurate 
solutions. The acquisition of a partial volume up to the angle of rotation supported more 
accurate motion compensation than acquiring bi-plane configurations. Additional intra-
procedural 3D TRUS image information was more beneficial to registration accuracy in 
the base and apex regions as compared with the mid-gland region 
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1.10.4 Chapter 5 – Robust 2D-3D registration optimization to motion 
compensation using learned prostate motion data 
In the previous chapter, we investigated a mechanism to achieve robust registration for 
motion compensation during biopsy by acquiring additional intra-procedure image 
information.  In this chapter, we discuss an alternative approach to registration to 
improve accuracy and robustness.  We developed and evaluated a registration algorithm 
in which the optimization is based on learned prostate motion characteristics of the 
prostate. We performed an unsupervised clustering of rigid prostate motion vectors 
observed in our data set.  We developed a multi-start search strategy, starting at each 
cluster mean and then directing the search towards the areas where motion vectors  had 
already been observed by appropriately scaling the search space and specifying the initial 
search directions during optimization using the Powell’s direction set method.   
Prostate motion analysis and registration validation was performed using a leave-
one-out-cross-validation approach using the 3D TRUS images acquired from 29 patients 
at baseline and sextant template biopsy locations.  With this method the RMS TRE ± std 
improved from 4.9 ± 2.35 mm to 2.3 ± 1.1 mm. The initial approach described in Chapter 
3 yielded an accuracy of 3.1 ± 1.7 mm with this data set.  Compared to the initial 
approach, the updated optimization method improved the robustness during 2D-3D 
registration by reducing the number of registrations with a TRE > 5 mm from 9.2% to 
1.2%.  With a total execution time of 2.8 s to perform motion compensation, this method 
is amenable to useful integration into a clinical 3D guided prostate biopsy workflow. 
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Chapter 2. 
Quantification of prostate deformation due to needle 
insertion during TRUS-guided biopsy: Comparison of 
hand-held and mechanically stabilized systems 
2.1 Introduction 
Prostate biopsy is currently the clinical standard for definitive diagnosis, and two-
dimensional (2D) transrectal ultrasound (TRUS) is the most common imaging modality 
used for guidance during biopsy. However, TRUS-guided biopsy suffers from significant 
limitations related to difficulties in targeting predefined locations within the prostate, 
resulting in a false negative rate as high as 29.1% [1].  The limited anatomic information 
provided by 2D TRUS makes navigation to predefined 3D locations challenging [2], and 
does not permit a 3D record of biopsy locations, which can be useful in a repeat session 
wherein previously-determined suspicious targets may need to be rebiopsied.   In order to 
overcome these drawbacks, magnetic resonance imaging (MRI) and TRUS guided 
systems have been developed to provide biopsy location information in 3D [3-5].  In 
these systems, biopsy target locations can be determined from previous biopsy sessions, 
or the radiologist's assessment of an image from a different modality. 
In order to be translated to clinical use, a biopsy system should meet the criterion 
of sampling tumours greater than or equal to a clinically significant minimum size with 
95% confidence.  A minimum significant prostate cancer volume of 0.5 cm3 (5 mm 
radius under an assumption of spherical tumour shape) has been previously established 
[6]. To meet the targeting criterion, the root-mean-square (RMS) error of a biopsy 
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system's delivery of needles to targets must be less than 2.5 mm [7].  There are several 
potential sources of error in biopsy systems: (1) mechanical guidance system errors, (2) 
imaging and calibration errors, (3) patient and prostate motion due to discomfort during 
the procedure, (4) prostate deformation due to biopsy needle insertion prior to firing the 
biopsy gun, and (5) prostate deformation due to biopsy gun firing.  The effects of the first 
three sources of error have been quantified previously [3, 5, 7].  The cumulative effect of 
all of the above sources has been quantified in the context of MRI-guided biopsy [8].  We 
hypothesize that deformations due to needle insertion and biopsy gun firing are different 
in the context of TRUS-guided biopsy due to several important differences in physical 
configuration.  In contrast to the robotic procedure described in Xu et al. [8], where an 
endorectal coil in a cylindrical housing is placed parallel to the rectal wall for imaging, 
TRUS-guided biopsy is typically conducted using an end-firing ultrasound transducer, 
where the spherical transducer tip is manipulated against the anterior rectal wall in order 
to obtain images.  The MR-guided robot in Xu et al. [8] inserts needles into the prostate 
through the rectal wall at an oblique angle to the endorectal coil housing, whereas in end-
firing TRUS biopsy, the needles are nearly parallel to the probe axis.  It is reasonable to 
expect that these differences in physical configuration may lead to differing mechanical 
dynamics at the time of biopsy needle insertion and gun firing, resulting in different 
prostate deformation characteristics.  The effect of needle insertion on prostate motion 
has been studied extensively in the context of brachytherapy procedures [9, 10], where 
the patient is under general anesthesia and the brachytherapy needles are inserted slowly 
(relative to the rapid firing speed of a biopsy gun) through the perineum.  It is reasonable 
to consider that the effect of the needle in the context of biopsy may be different due to 
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the reactions (e.g., in the form of pelvic floor muscle contractions) of an awake, 
uncomfortable patient and the high speed of needle insertion by the biopsy gun. 
The objective of this work was to quantify the deformation caused by the needle 
insertion and biopsy gun firing procedure.  The three main contributions of the present 
work are: (1) to compute clinically relevant confidence intervals around the tissue 
deformation, accounting for the measured error in our approach to measuring this 
deformation; (2) to compare the amount of lateral deformation, in the direction 
orthogonal to the needle, to the amount of axial deformation, in the direction parallel to 
the needle; and (3) to compare the deformation resulting from the traditional approach to 
2D TRUS-guided biopsy where the probe is hand held with that resulting from the use of 
mechanically assisted biopsy system [5].  With respect to contribution (1), we computed 
a spatially varying confidence interval around the amount of tissue deformation induced 
during these two actions in order to permit the determination the difference between the 
location sampled by the biopsy needle and the planned target location.  This is a useful 
measure from a clinical standpoint, since this confidence interval can be used to 
determine the smallest tumour that can be accurately sampled with 95% confidence, 
under the assumption of zero error in all other aspects of the biopsy system.  Our initial 
work on this problem, addressed this quantification in terms of a spatially varying mean 
and standard deviation of the deformation magnitudes [11].  With respect to contribution 
(2), given the long, narrow (19 mm × 0.8 mm) cylindrical shape of the biopsy core, it is 
useful to decompose the tissue motion into its axial and lateral components, since axial 
motion poses less of a problem for targeting, compared to lateral motion.  With respect to 
contribution (3), we hypothesize that the characteristics of prostate deformation may 
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differ when using a hand held TRUS probe during needle insertion and gun firing, as 
compared with using our mechanically stabilized system where the interaction between 
the physician and the system is more controlled.   
2.2 Materials and Methods 
2.2.1 Data Acquisition 
We acquired images using a conventional hand held 2D-TRUS biopsy system and a 
mechanically assisted 3D TRUS biopsy guidance system developed in our laboratory [5] 
as part of a larger human subjects research ethics board approved MRI-3D TRUS fusion 
biopsy study of our institution.  This system consists of passive mechanical components 
for guiding, tracking and stabilizing the position and orientation of a conventional TRUS 
probe (Figure 2.1).  The stabilization is accomplished using a mechanical spring-loaded 
counter-balancing system that maintains the position and orientation of the probe even 
when the physician removes his hand from the handle.  This permits smooth motion of 
the transducer with a light touch of the physician's hand.  In addition, the configuration of 
the device is such that there exists a remote center of motion (RCM) at a point near to the 
tip of the TRUS probe.  The RCM is intended to minimize prostate motion during 
reorientation of the probe to aim for different targets in the biopsy plan. 
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Figure 2.1: Mechanically assisted 3D TRUS-guided biopsy system.  The biopsy gun is retained in a clip 
and the needle is coupled to the TRUS probe using a needle guide.  A spring-based counter balancing 
system maintains probe position and orientation even when the physician removes his hand from the probe. 
  
For both the hand held and mechanically assisted approaches, we used a 
Philips/ATL HDI 5000 ultrasound machine with a 5-9 MHz end-firing TRUS transducer 
probe (model C9-5, Philips, Bothell, WA, USA) to acquire images, and a Magnum 
biopsy gun (C. R. Bard, AZ, USA) to take biopsy samples.  We utilized a video capture 
board to acquire and digitize video from the ultrasound machine's composite video output 
at a minimum of 10 Hz, recording the 2D ultrasound images (with isotropic pixels of size 
0.19 mm) obtained during the entire biopsy procedure for each patient.  Across 16 
patients, 𝑁𝑠 = 190 biopsies were obtained (i.e., an average of 12 biopsies per patient).  96 
biopsies were taken from 9 patients using the hand held system, and 94 biopsies were 
taken from 7 patients using the mechanically assisted system.  For each biopsy, we 
manually selected 3 video frames, denoting each frame triplet as a biopsy sequence, each 
of which is assigned a number 𝑠 between 1 and 𝑁𝑠.  The sequence consists of (1) the 
image 𝐼𝑠1 acquired immediately prior to needle insertion, (2) the image 𝐼𝑠2 acquired 
Biopsy gun clip
Spring loaded 
counterbalance
Needle guide
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immediately prior to biopsy gun firing, and (3) the image 𝐼𝑠3 acquired immediately after 
biopsy gun firing (Figure 2.2).  Formally, 𝐼𝑠𝑖: Ω → ℝ, where 𝑖 ∈  {1,2,3}, 𝑠 ∈  {1…𝑁𝑠}, 
and Ω ⊂  ℝ2 represents the domain of the image. 
 
Figure 2.2: Images in a biopsy sequence, and the names used for the three indicated registrations 
throughout this paper.  The first image occurs immediately prior to the physician's insertion of the biopsy 
needle.  The second image occurs immediately prior to firing the biopsy gun, and the third image occurs 
immediately after the biopsy gun has been fired.  The dotted curves indicate portions of the prostate 
boundary that interact with the needle, which lies between the two solid vertical segments in the second and 
third images; note the deformation at the lower piercing point. 
2.2.2 Image registration 
Our method is described at a high level in the block diagram given in Figure 2.3.   The 
process begins with the registration of an image pair, where one image is designated as 
the fixed image, and the other is designated as the moving image.  For each biopsy 
sequence, we performed three such registrations, described in Figure 2.3.  Throughout the 
remainder of this paper, for a biopsy sequence 𝑠, registration 1 refers to the registration of 
𝐼𝑠1 to 𝐼𝑠3 and reports the combined deformation resulting from both the needle insertion 
and the biopsy gun firing procedures.  Registration 2 refers to the registration of 𝐼𝑠1 to 𝐼𝑠2 
and reports the deformation resulting from needle insertion only.  Registration 3 refers to 
the registration of 𝐼𝑠2 to 𝐼𝑠3 and reports the deformation resulting from biopsy gun firing 
only.  For each indicated image pair, we designated the image at the earlier time point as 
the moving image and the image at the later time point as the fixed image, since these 
Registration 1 Registration 2
Registration 3
After needle insertion
Before needle insertion After biopsy gun firing
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designations reflect the movement of the tissue through time during the procedure.  We 
normalized the images with respect to the position of the biopsy needle by flipping the 
images (if necessary) so that the needle lies to the left of the probe; this normalization 
allows for the straightforward quantification of deformation with respect to measured 
spatial distances to the needle.  We then non-rigidly registered the moving image to the 
fixed image, yielding a deformation vector field that we used to quantify the tissue 
deformation captured by the registration.  The deformation field resulting from 
registration 𝑟 of biopsy sequence 𝑠 is denoted 𝑉𝑠𝑟: Ω → ℝ
2 and gives the magnitude and 
direction of deformation at each location in the image domain.  We refer to the lateral (𝑥) 
and axial (𝑦) components of the deformation field as 𝑉𝑠𝑟
𝑥: Ω → ℝ and 𝑉𝑠𝑟
𝑦: Ω → ℝ, 
respectively; Figure 2.4 provides an illustration of the magnitudes of 𝑉𝑠𝑟, 𝑉𝑠𝑟
𝑥, and 𝑉𝑠𝑟
𝑦
 for 
one sequence.  We tested the following three registration algorithms, with the specified 
tuning parameters: (1) Demons [12] (standard deviation of smoothing kernel: 1 mm, 
number of histogram levels: 1024, number of match points: 7), symmetric forces Demons 
[13] (using the same parameters as for the Demons algorithm) and B-spline [14] (B-
spline order: 3, grid spacing: 0.72 mm, similarity metric: normalized cross correlation). 
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Figure 2.3: Overall process used in this work. The moving image (from an earlier time point) is registered 
to the fixed image (from a later time point) using non-rigid registration.  This yields a deformation vector 
field that is used to quantify the underlying motion of the tissue.  The error in the non-rigid registration 
algorithm is measured by calculating a TRE based on corresponding intrinsic fiducial markers.  
Measurements, incorporating the TRE, are then taken from the deformation vector field to characterize the 
underlying motion of the prostate tissue in response to the insertion of the biopsy needle and firing of the 
biopsy gun. 
 
Figure 2.4: (a) Deformation vector field magnitude with prostate boundary and needle location indicated. 
(b) Lateral (x) components of the deformation field. (c) Axial (y) components of the deformation field. The 
needle axis lies between the vertical white line is each image. 
2.2.3 Image registration validation 
The accuracy of a deformation vector field in describing the motion of the tissue depicted 
in the registered images is influenced by the error of the registration algorithm that 
generated the deformation vector field.    We evaluated each image registration algorithm 
by estimating its TRE using manually marked, anatomically homologous intrinsic 
fiducial markers (naturally occurring calcifications) visible in a subset of the images to be 
registered (Figure 2.5).  The TRE is calculated as the RMS error of the spatial locations 
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of corresponding fiducials, post-registration [15].  To compute the TRE for each 
algorithm, we performed registrations 1, 2, and 3 on 21 biopsy sequences taken from 4 
patients.  A total of 390 fiducials were identified and localized in the tested images.  To 
determine the location of each fiducial, an operator localized the fiducial five times 
during separate sessions, and the centroid (arithmetic mean) of the operator's five selected 
locations was taken as the estimate of the location of the fiducial.  These repeated 
localizations were also used to compute the fiducial localization error (FLE) as 𝐹𝐿𝐸 =
 √
1
𝑁
∑ 𝐹𝐿𝐸𝑘
2
𝑘 , where 𝐹𝐿𝐸𝑘
2 = 𝜎2(𝑥𝑘) + 𝜎
2(𝑦𝑘), and 𝜎
2(𝑥𝑘) and 𝜎
2(𝑦𝑘) are the 
variances of the 𝑥- and 𝑦-coordinates, respectively, of the repeated localizations of the 𝑘th 
fiducial. 
 
Figure 2.5: Calcifications used to validate the registration algorithms, indicated by arrows. 
2.2.4 Quantification of deformation 
A clinical objective of image-guided prostate biopsy is to obtain tissue samples from 
regions of the prostate defined as biopsy targets.  In conventional 2D TRUS-guided 
  
55 
 
biopsy, these targets may be determined according to a predefined pattern (e.g., as in 
sextant biopsy), or may be determined at time of biopsy based on a visual assessment of 
the ultrasound image by the physician.  In 3D TRUS-guided systems [3, 5], targets may 
be determined via the physician's assessment of an image of a different modality (e.g., 
MRI) or based on biopsy targets in a previous 3D TRUS-guided biopsy session [7].  
Regardless of the means of defining the target, the physician will insert the biopsy needle 
through the rectal wall with a trajectory intersecting with the target, advancing the needle 
tip sufficiently such that the target lies within the throw of the biopsy gun, and then 
activate the trigger to fire the gun and obtain a sample.  It is therefore of interest to 
quantify the deformation of the prostate tissue proximal to the trajectory of the needle 
throughout this procedure, in order to determine how far the target may move from the 
needle path.  There are two key aspects to this quantification: (1) defining the appropriate 
statistical descriptions of the deformation field to characterize the underlying tissue 
motion within a confidence interval, and (2) defining relevant spatial regions within 
which these statistics are to be calculated.  We define the statistics in Section 2.2.4.1 and 
the spatial regions in Section 2.2.4.2.  In Section 2.2.4.2, we describe the specific 
measurements computed in this paper using the defined statistics and regions. 
2.2.4.1 Deformation vector field statistics 
We calculated three statistics: (1) a signed mean of the deformation vector field, to 
measure coherent tissue motion in some direction; (2) a standard deviation of the vector 
field, to obtain a confidence interval around the amount of deformation observed in the 
tissue; and (3) a standard deviation of the vector field that incorporates the measurement 
error given by the TRE. 
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Statistic 1: Signed mean of the deformation field. This statistic was computed 
by summing each of the two signed components of the deformation vectors 
independently, and squaring and adding the results to obtain a measure of coherence in 
the motion depicted by the deformation vector field.  The signed mean distance across all 
sequences for a particular registration 𝑟 (1, 2 or 3) is defined as 
?̅?𝑟(𝑃) =  ‖
1
𝑁𝑠
∑ (
1
|𝑃𝑠|
)∑ 𝑉𝑠𝑟(𝒑𝑖 ∈  𝑃𝑠)
|𝑃𝑠|
𝑖=1
𝑁𝑠
𝑠=1 ‖, 
(2.1) 
where 𝑃 = {𝑃1, 𝑃2, … , 𝑃𝑁𝑠} is a set of point sets, one per sequence, and |𝑃𝑠| is taken to be 
the cardinality of set 𝑃𝑠. The parameter 𝑃 allows for the specification of the region of the 
deformation vector field over which the statistic is to be computed. The elements of 
𝑃 allow for the definition of a different region for each sequence.  
Statistic 2: Standard deviation of the deformation field. The standard deviation 
of the distribution of deformation vectors for all sequences for a registration 𝑟 is  
?̃?𝑟(𝑃) = √?̂?𝑟(𝑃)2 − ?̅?𝑟(𝑃)2, (2.2) 
where the RMS of the deformation is defined as 
?̂?𝑟(𝑃) =  
1
𝑁𝑠
∑ (
1
|𝑃𝑠|
∑ ‖𝑉𝑠𝑟(𝒑𝑖 ∈  𝑃𝑠)‖
|𝑃𝑠|
𝑖=1 )
𝑁𝑠
𝑠=1 . 
(2.3) 
The standard deviation ?̃?𝑟(𝑃) is a useful statistic in that it permits the calculation 
of a confidence interval around the amount of tissue motion in a region of interest defined 
by 𝑃. However, ?̃?𝑟(𝑃) represents the variability of the deformation of the prostate tissue 
under the assumption of zero measurement error, i.e., zero TRE. Our motivation for 
performing this calculation is to compare it with the analogous calculation (defined in the 
next paragraph) that incorporates the TRE, in order to assess the impact of the 
registration error on the computed confidence interval on the estimated tissue motion. 
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Statistic 3: Standard deviation of the deformation field, incorporating the 
TRE.  In a given registration of a moving image to a fixed image, every point in the 
moving image has an anatomically homologous point in the fixed image to which it 
would be transformed by an ideal registration algorithm.  In practice, a given registration 
algorithm transforms each point in the moving image to a point which is some (possibly 
nonzero) distance away from its anatomically homologous point in the fixed image.  If 
we define the anatomically homologous point given by the ideal registration algorithm as 
our “true target”, the error of a non-ideal registration algorithm places the transformed 
points from the moving image around the true target according to some distribution.  
Under the assumption that this distribution is normal, the TRE gives an estimate of its 
standard deviation.  Deformation vector fields generated by a registration algorithm with 
a nonzero TRE therefore give an approximate measure of the deformation of the tissue, 
which is reflected in a larger confidence interval on the estimated tissue deformation due 
to needle insertion and biopsy gun firing.  The TRE, measured as an RMS error, adds 
uncertainty regarding the tissue motion to the uncertainty described by the measured 
standard deviation of the deformation vector field.  These uncertainties are combined by 
taking their quadratic sum [16] as 
𝜎𝑟(𝑃) = √?̃?𝑟(𝑃)2 + 𝑇𝑅𝐸2, (2.4) 
The 95% confidence interval on the magnitude of the prostate tissue displacement 
is given by 1.96𝜎𝑟(𝑃). To measure the tissue deformation along the lateral (𝑥) and axial 
(𝑦) directions separately, we computed  
𝜎𝑟
𝑥(𝑃) = √?̃?𝑟
𝑥(𝑃)2 + (𝑇𝑅𝐸𝑥)2 and (2.5) 
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𝜎𝑟
𝑦(𝑃) = √?̃?𝑟
𝑦(𝑃)2 + (𝑇𝑅𝐸𝑦)2, 
(2.6) 
respectively, where 𝑇𝑅𝐸𝑥 and 𝑇𝑅𝐸𝑦 are the dimensional components of the TRE, and  
?̃?𝑟
𝑥(𝑃) = √?̂?𝑟
𝑥(𝑃)2 − ?̅?𝑟
𝑥(𝑃)2,  
  ?̅?𝑟
𝑥(𝑃) =  ‖
1
𝑁𝑠
∑ (
1
|𝑃𝑠|
)∑ 𝑉𝑠𝑟
𝑥(𝒑𝑖 ∈  𝑃𝑠)
|𝑃𝑠|
𝑖=1
𝑁𝑠
𝑠=1 ‖, 
 
 
?̂?𝑟
𝑥(𝑃) =  
1
𝑁𝑠
∑ (
1
|𝑃𝑠|
∑ ‖𝑉𝑠𝑟
𝑥(𝒑𝑖 ∈  𝑃𝑠)‖
|𝑃𝑠|
𝑖=1 )
𝑁𝑠
𝑠=1 . 
 
(and similarly for the 𝑦 dimension). 
2.2.4.2 Measured regions 
We calculated the statistics of deformation vector fields lying within three different types 
of image regions: (1) regions at a specific signed distance to the needle axis, (2) regions 
within an unsigned distance of the needle axis, and (3) regions at a specific unsigned 
distance to the point where the biopsy needle enters the prostate (henceforth referred to as 
the lower piercing point). 
Region 1: Deformation vectors at a signed distance to the needle axis. The set 
of points in the image domain lying at a distance 𝑑 from the needle axis 𝐴 for sequence 𝑠 
is defined as 
𝑃𝑠𝑑
𝐴 = {𝒑𝑖 ∈ Ω | 𝐷𝐴(𝐴𝑠, 𝒑𝑖) = 𝑑}, (2.7) 
where 
𝐴𝑠 = {𝒍𝑠 +  𝑡𝒂𝑠 | 𝑡 ∈ ℝ},  
defines the needle axis for sequence 𝑠, with 𝒍𝑠 defining the lower piercing point and 𝒂𝑠 
defining the needle axis direction. 𝐷𝐴(𝐴𝑠, 𝒑𝑖) gives the signed perpendicular distance 
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between 𝒑𝑖 and the needle axis, with negative distance values defined for points lying to 
the left of the needle axis. 𝑃𝑑
𝐴 = {𝑃1𝑑
𝐴 , 𝑃1𝑑
𝐴 , … , 𝑃𝑁𝑠𝑑
𝐴 } the set of such regions at distance 𝑑 
for all sequences.  
Region 2: Deformation vectors within an unsigned distance of the needle axis. 
The set of points from sequence 𝑠 in the image domain lying within a region of the 
needle axis (“axis region” denoted as 𝐴𝑅) defined by a distance 𝑑 is defined as 
𝑃𝑠𝑑
𝐴𝑅 = {𝒑𝑖 ∈ Ω | 𝐷𝐴(𝐴𝑠, 𝒑𝑖)  ≤ 𝑑}. (2.8) 
𝑃𝑑
𝐴𝑅 = {𝑃1𝑑
𝐴𝑅 , 𝑃1𝑑
𝐴𝑅 , … , 𝑃𝑁𝑠𝑑
𝐴𝑅 }, the set of such regions at distance 𝑑 for all sequences. 
Region 3: Deformation vectors at a specific unsigned distance to the lower 
piercing point.  The set of points in the image domain lying at a distance d from the 
lower (denoted as “𝑙”) piercing point for sequence 𝑠 is defined as 
𝑃𝑠𝑑
𝑙 = {𝒑𝑖 ∈ Ω | 𝐷𝑙(𝒍𝑠, 𝒑𝑖) = 𝑑}, (2.9) 
where 𝐷𝑙(𝒍𝑠, 𝒑𝑖) gives the unsigned Euclidean distance between 𝒑𝑖 and the lower 
piercing point. 𝑃𝑑
𝑙 = {𝑃1𝑑
𝑙 , 𝑃1𝑑
𝑙 , … , 𝑃𝑁𝑠𝑑
𝑙 }, the set of such regions at distance 𝑑 for all 
sequences. 
2.2.4.3 Prostate tissue deformation measurements 
Using the statistics and regions defined above, we computed four different measures of 
prostate tissue deformation, defined in the paragraphs below. 
Measurement 1: Deformation as a function of distance to the needle axis. The 
signed mean, ?̅?𝑟(𝑃𝑑
𝐴), the standard deviation, ?̃?𝑟(𝑃𝑑
𝐴), and the standard deviation 
incorporating the TRE, 𝜎𝑟(𝑃𝑑
𝐴), were determined for regions 𝑃𝑑
𝐴 at specific signed 
distances 𝑑 to the needle axis (Figure 2.6). These measurements were performed 
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separately for 𝑟 = 1,2,3, with 𝑑 = [-15 mm, 50 mm], a sufficiently large domain to cover 
all of the prostates in our study.  The purpose of these measurements was to find the 95% 
confidence interval (1.96𝜎𝑟(𝑃𝑑
𝐴)) on the estimated prostate tissue motion, as well any 
directionally coherent tissue motion (?̅?𝑟(𝑃𝑑
𝐴)), as a function of distance to the needle 
axis.  Since the biopsy target is presumably near to the needle axis, these measurements 
allow for the interrogation of a region of clinical interest to determine the amount by 
which the tissue may move away from the needle during biopsy.  Comparing the 95% 
confidence interval on the tissue motion that incorporates the measured TRE with the 
corresponding confidence interval computed under the assumption of zero TRE permits 
the assessment of the effect of the registration error on the confidence interval estimate. 
 
Figure 2.6: Diagram depicting a prostate contoured on a 2D TRUS image with the needle axis 𝐴𝑠 to the 
left of the probe, as in all of our images. The perpendicular distance 𝐷𝐴 of a point 𝑃 to the needle axis is 
shown. The lower piercing point 𝑙𝑠 is indicated, as is the distance 𝐷𝑙 between 𝑃 and the lower piercing 
point. 
Measurement 2: Deformation as a function of distance to the lower piercing 
point. The signed mean, ?̅?𝑟(𝑃𝑑
𝑙 ), the standard deviation, ?̃?𝑟(𝑃𝑑
𝑙), and the standard 
deviation incorporating the TRE, 𝜎𝑟(𝑃𝑑
𝑙), were determined for regions 𝑃𝑑
𝑙  at specific 
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unsigned distances 𝑑 to the lower piercing point (Figure 2.6). These measurements were 
performed separately for 𝑟 = 1, 2, 3, with 𝑑 = [0 mm, 30 mm], a sufficiently large domain 
to cover all of the prostates in our study. The purpose of these measurements was to find 
the 95% confidence interval (1.96𝜎𝑟(𝑃𝑑
𝑙)) on the estimated prostate tissue motion, as well 
any directionally coherent tissue motion (?̅?𝑟(𝑃𝑑
𝑙 )), as a function of distance to the lower 
piercing point. These measurements allow for the comparison of the amounts by which 
the tissue may move away from the biopsy needle when the target is proximal to the 
piercing point (e.g., target A in Figure 2.7), and when the target is far from the piercing 
point (e.g., target B in Figure 2.7). This is particularly important since up to 80% of 
prostate cancer is found in the peripheral zone [17, 18], which lies near to the posterior 
side where the biopsy needle enters the prostate after penetrating the rectal wall (Figure 
2.7). 
  
Figure 2.7: Diagram depicting prostate anatomy in a sagittal view, indicating the peripheral zone (PZ), 
central zone (CZ), transition zone (TZ), and anterior zone (AZ). Three biopsy targets are shown as A, B, 
and C. The biopsy needle enters the prostate on the posterior side by penetrating the rectal wall, as shown. 
Measurement 3: Deformation in the lateral and axial directions. The standard 
deviations incorporating the TRE along the lateral (𝑥) and axial (𝑦) directions for 
registration 1, computed as 𝜎1
𝑥(𝑃𝑑
𝐴) (Equation 2.5) and 𝜎1
𝑦(𝑃𝑑
𝐴) (Equation 2.6), 
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respectively, were determined for regions 𝑃𝑑
𝐴 at specific signed distances 𝑑 to the needle 
axis (Equation 2.7). 𝜎1
𝑥(𝑃𝑑
𝑙 )  and 𝜎1
𝑦(𝑃𝑑
𝑙 )  are also calculated for regions 𝑃𝑑
𝑙  at specific 
unsigned distances 𝑑 to the lower piercing point (Equation 2.9).  These give 
decompositions of the two quantifications described above into the lateral and axial 
directions. The observation of these decompositions is useful because of the highly 
anisotropic (long, narrow) nature of the biopsy core; axial tissue motion parallel to the 
needle poses less of a problem with respect to targeting than does lateral tissue motion. 
Measurement 4: Deformation as a function of lateral position of the needle 
relative to the prostate. The standard deviation incorporating the TRE, computed as 
𝜎1(𝑃5 𝑚𝑚
𝐴𝑅 ), was determined for the region 𝑃5 𝑚𝑚
𝐴𝑅  within 5 mm of the needle axis 
(Equation 2.8). This was calculated for registration 1 as a function of 𝑤, the lateral 
position of the needle normalized with respect to the width of the prostate as seen on the 
2D TRUS image.  At the boundary of the prostate on the 2D TRUS image on the left side 
of the needle, 𝑤 = 0, in the middle of the prostate, 𝑤 = 0.5, and at the boundary of the 
prostate on the right side of the needle, 𝑤 = 1.  The purpose of this measurement is to 
investigate the relationship (if any) between the distance of the target from the edge of 
the prostate, and the amount of tissue deformation that occurs within a clinically 
meaningful distance of the needle axis. This is illustrated by Figure 2.7; this measurement 
permits the determination of the difference in deformation when aiming the needle for 
target A (closer to the middle of the prostate), compared to target C (closer to the edge of 
the prostate). 
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2.3 Results 
2.3.1 Image registration validation 
Table 1 shows the measured TRE values before and after registration for each of the 
tested algorithms. The symmetric forces Demons registration algorithm was selected for 
use in this study since it provided the best overall improvement in the TRE.  This 
algorithm is based on optical flow techniques, which have been shown to be suitable for 
tracking fine-scale structure in ultrasound images in the presence of small tissue 
deformation [19]; this class of algorithms is therefore suitable for our problem.  The 
calculated FLE was 0.11 mm. 
Table 2.1: Comparison of TRE before and after registration for each tested registration method.  
Registration 1 captures tissue motion during needle insertion and biopsy gun firing, registration 2 captures 
needle insertion only, and registration 3 captures biopsy gun firing only. 
Registration method Registration 1 TRE 
(mm) 
Registration 2 
TRE (mm) 
Registration 3 
TRE (mm) 
Before registration 0.51 0.31 0.40 
Demons [12] 0.24 0.13 0.23 
Symmetric Forces Demons [13] 0.23 0.14 0.22 
B-spline [14] 0.46 0.28 0.37 
2.3.2 Quantification of deformation 
Measurement 1: Deformation as a function of distance to the needle axis. Figure 2.8 
plots the mean deformation, ?̅?𝑟(𝑃𝑑
𝐴), the 95% confidence interval, 1.96?̃?𝑟(𝑃𝑑
𝐴), and the 
95% confidence interval incorporating the TRE, 1.96𝜎𝑟(𝑃𝑑
𝐴), versus the signed distance 
𝑑 to the needle axis.  It can be observed that the coherent tissue motion is relatively small 
compared to the total amount of deformation (comparing the lowermost curve to the 
uppermost curve), and that the TRE makes a relatively small contribution to the width of 
the 95% confidence interval (comparing the middle curve to the uppermost curve).  A 
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local increase in deformation proximal to the needle axis is observed for both systems, 
with biopsy gun firing being the main contributor to this deformation for the hand held 
system, and the only contributor for the mechanically assisted system.  A two-tailed t-test 
showed that 1.96𝜎𝑟(𝑃𝑑
𝐴) was statistically significantly different when comparing the hand 
held system to the mechanically assisted system (p < 0.05), for |𝑑| < 20 mm. 
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Figure 2.8: Deformation versus distance to the needle axis.  Dashed curve: the signed mean of the 
deformation (?̅?𝑟(𝑃𝑑
𝐴)).  Dotted curve: the 95% confidence interval around the tissue deformation (?̃?𝑟(𝑃𝑑
𝐴)).  
Solid curve: the 95% confidence interval incorporating the TRE (𝜎𝑟(𝑃𝑑
𝐴)). (a, b): registration 1, (c, d): 
registration 2, (e, f): registration 3.  (a, c, e): hand held, (b, d, f): mechanically assisted. 
(a) (b)
(c) (d)
(e) (f)
Reg. 1
Reg. 2
Reg. 3
Hand held Mechanically assisted 
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Figure 2.9: Deformation versus distance to the lower piercing point.  Dashed curve: the signed mean of the 
deformation (?̅?𝑟(𝑃𝑑
𝑙 )).  Dotted curve: the 95% confidence interval around the tissue deformation (?̃?𝑟(𝑃𝑑
𝑙 )).  
Solid curve: the 95% confidence interval incorporating the TRE (𝜎𝑟(𝑃𝑑
𝑙 )). (a, b): registration 1, (c, d): 
registration 2, (e, f): registration 3.  (a, c, e): hand held, (b, d, f): mechanically assisted. 
 
(a) (b)
(c) (d)
(e) (f)
Reg. 1
Reg. 2
Reg. 3
Hand held Mechanically assisted 
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Measurement 2: Deformation as a function of distance to the lower piercing 
point.  Figure 2.9 plots the mean deformation, ?̅?𝑟(𝑃𝑑
𝑙), the 95% confidence interval,  
1.96?̃?𝑟(𝑃𝑑
𝑙), and the 95% confidence interval incorporating the TRE, 1.96𝜎𝑟(𝑃𝑑
𝑙), versus 
the signed distance 𝑑 to the needle axis.  As in Figure 2.8, it can be observed that the 
coherent tissue motion is small relative to the total amount of deformation and that the 
TRE is not a substantially contributing factor. It can also be observed that in general, 
more deformation occurs proximal to the lower piercing point. A two-tailed t-test showed 
that 1.96𝜎𝑟(𝑃𝑑
𝑙) was statistically significantly different when comparing the hand held 
system to the mechanically assisted system (p < 0.05), for 𝑑  ≥ 1 mm. 
Measurement 3: Deformation in the lateral and axial directions. Figure 
2.10(a-b) plot the 95% confidence interval on the tissue deformation, 1.96𝜎1(𝑃𝑑
𝐴), versus 
distance to the needle axis, and its lateral and axial components, 1.96𝜎1
𝑥(𝑃𝑑
𝐴) and 
1.96𝜎1
𝑦(𝑃𝑑
𝐴), respectively. Figure 2.10(c-d) plot the 95% confidence interval on the tissue 
deformation, 1.96𝜎1(𝑃𝑑
𝑙), versus distance to the lower piercing point, and its lateral and 
axial components, 1.96𝜎1
𝑥(𝑃𝑑
𝑙 ) and 1.96𝜎1
𝑦(𝑃𝑑
𝑙), respectively.  It can be observed that the 
deformation is predominantly in the lateral (𝑥) direction proximal to the needle axis (a-b).  
Proximal to the lower piercing point (c-d), the situation is the opposite, with dependence 
predominantly in the axial (𝑦) direction. 
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Figure 2.10: Lateral-axial decompositions of the 95% confidence intervals shown in Figures 8 and 9, for 
registration 1.  (a, b): Deformation versus distance to the needle axis.  Solid curve: the 95% confidence 
interval around the tissue deformation incorporating the TRE (𝜎𝑟(𝑃𝑑
𝐴)).  Dashed curve: the lateral (𝑥) 
component of this confidence interval (𝜎1
𝑥(𝑃𝑑
𝐴))  Dotted curve: the axial (𝑦) component (𝜎1
𝑦(𝑃𝑑
𝐴)).  (c, d): 
Deformation versus distance to the lower piercing point.  Solid curve: the 95% confidence interval around 
the tissue deformation incorporating the TRE (𝜎𝑟(𝑃𝑑
𝑙 )).  Dashed curve: the lateral (𝑥) component of this 
confidence interval (𝜎1
𝑥(𝑃𝑑
𝑙 )).  Dotted curve: the axial (𝑦) component (𝜎1
𝑥(𝑃𝑑
𝑙 )) (a, c): hand held, (b, d): 
mechanically assisted. 
Measurement 4: Deformation as a function of lateral position of the needle 
relative to the prostate. Figure 2.11 plots the 95% confidence interval on the tissue 
deformation in the region within 5 mm of the needle axis, 1.96𝜎1(𝑃5 𝑚𝑚
𝐴𝑅 )as a function of 
the position of the biopsy needle relative to the left edge of the prostate as seen on the 2D 
TRUS image (0 is the left edge, 1 is the right edge, and 0.5 is the middle). Since the 
(a) (b)
(c) (d)
Reg. 1
Reg. 2
Hand held Mechanically assisted 
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needle is consistently oriented to the left side of the probe in our images, most of the 
plotted points are at less than 0.5 on the horizontal axis. The correlation ratio was found 
to be -0.17, with a 95% confidence interval of (-0.07, -0.27). The relationship is weak, 
negative as shown in Figure 2.11. 
 
Figure 2.11: Deformation as a function of lateral position of the needle relative to the prostate, for 
registration 1. The distance to the left edge of the prostate is shown on the horizontal axis (0 = left edge, 0.5 
= middle, 1 = right edge). The vertical axis shows the width of the 95% confidence interval on the tissue 
deformation within a region lying 5 mm on either side of the needle axis (𝜎1(𝑃5 𝑚𝑚
𝐴𝑅 )). The best fit line is 
plotted, showing a weak negative relationship (r = -0.17).  
2.4 Discussion 
2.4.1 Image registration validation 
The measured TRE values before and after registration using the symmetric forces 
Demons algorithm demonstrate that the registrations improve the alignment of the 
fiducial markers for registrations 1, 2, and 3.  Overall, for registration 1 (capturing tissue 
deformation occurring during needle insertion and biopsy gun firing), 55% of the pre-
registration fiducial misalignment is eliminated by the algorithm. For registrations 2 
(needle insertion only) and 3 (biopsy gun firing only), 55% and 45% of the pre-
registration fiducial misalignment is eliminated, respectively, suggesting that the 
algorithm was most challenged by the registration of the images occurring before and 
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after biopsy gun firing. Although the FLE accounts for less than half of the TRE for the 
overall biopsy procedure (registration 1), it contributes non-trivial variability, suggesting 
that the actual TRE of this algorithm may in fact be lower than our measurements 
suggest. Our reported confidence intervals are therefore likely to be conservative. 
2.4.2 Quantification of deformation 
Measurement 1: Deformation as a function of distance to the needle axis.  We 
observe a maximum value of 1.96𝜎1(𝑃𝑑
𝐴) = 2.1 mm, occurring at 𝑑 = 0, across both 
systems.  Consequently, spherical tumours with radius 2.1 mm or more can be sampled 
with 95% confidence, under the assumption of zero error elsewhere in the biopsy system.  
Although 1.96𝜎1(𝑃𝑑
𝐴) has a higher plateau for the mechanically assisted system, 
compared to the hand held system, the difference in deformation in the region along the 
needle axis is less than 0.38 mm.  This slight increase in deformation may be explained 
by the fact that the mechanical system, due to its stabilization of the ultrasound probe, 
does not require the physician to maintain constant inward pressure on the probe to keep 
it within the rectum with good acoustic coupling to the prostate.  Although this 
stabilization can reduce the amount of deformation applied to the prostate as the probe is 
reoriented to aim for different targets, the reduced pressure on the prostate may permit 
the observed increase in tissue motion during needle insertion and biopsy gun firing.  In 
addition, there is less variability arising from the mechanical system in the deformation 
on the lateral side of the prostate, to the left of the needle axis (compare Figure 2.8(a,e) to 
Figure 2.8(b,f) for 𝑑 < 0).  Feedback from our collaborating radiologist suggests that this 
may be due to the mechanical system's stability in the absorption of recoil when the 
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biopsy gun is fired; recall that the mechanically assisted system holds the biopsy gun in a 
clip, allowing its mechanical assembly to stabilize the gun and needle during firing.  In 
the hand held system, the physician may be inclined to proactively compensate for recoil 
by driving the biopsy gun forward slightly at the time of firing, causing the observed 
lateral deformation variability. Additionally, there exists a relative increase in 
deformation in the region surrounding the needle axis for the hand held system during 
needle insertion (peak in the curve at 𝑑 = 0 in Figure 2.8(c)); this does not occur in the 
mechanically assisted system (no peak in the curve at 𝑑 = 0 in Figure 2.8(d)).  This may 
be due to a slower speed of needle insertion in the mechanical system due to the fact that 
biopsies taken with this system were targeted using a heads-up display, causing the 
physician to take extra care when setting the initial needle trajectory during penetration of 
the rectal wall. 
Measurement 2: Deformation as a function of distance to the lower piercing 
point. As was observed with the deformation relative to the needle axis, the deformation 
relative to the lower piercing point, 1.96𝜎1(𝑃𝑑
𝑙), is 0.38 mm higher in the mechanically 
assisted system, compared with the hand held system. Overall, the mechanically assisted 
approach yields a deformation that is less dependent on the distance from the lower 
piercing point, compared with the hand held approach (flatter curves in Figure 2.9(b, d, 
f), compared with Figure 2.9(a, c, e)). 
Measurement 3: Deformation in the lateral and axial directions. At 𝑑 = 0, the 
ratio of 𝜎1
𝑥(𝑃𝑑
𝐴) to 𝜎1
𝑦(𝑃𝑑
𝐴) is 1.2 for the mechanically assisted system, and 1.3 for the 
hand held system.  The observed lateral tissue motion proximal to the needle shaft is 
expected, since tissue must be displaced laterally in order to accommodate the insertion 
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of the biopsy needle into the prostate; this observation provides qualitative support for the 
plausibility of the deformation vector fields generated by our chosen registration 
algorithm.  This analysis is motivated by the long, narrow shape of the biopsy core, so it 
is of value to observe the 95% confidence interval around the lateral tissue motion along 
the needle axis.  This quantity is 1.3 mm for the hand held system and 1.5 mm for the 
mechanically assisted system.  In both systems, the ratio of 𝜎1
𝑦(𝑃𝑑
𝑙 ) to 𝜎1
𝑥(𝑃𝑑
𝑙 ) is greater 
than one proximal to the lower piercing point; this dependence is in the axial direction, 
parallel to the needle axis, and so is of little concern given the shape of the biopsy core. 
Measurement 4: Deformation as a function of lateral position of the needle 
relative to the prostate. The observed weak negative relationship between 
1.96𝜎1(𝑃5 𝑚𝑚
𝐴𝑅 ) and the lateral position of the biopsy needle relative to the prostate 
suggests that although the tissue medial to the prostate may be more stable during biopsy, 
compared with the tissue nearer to the sides, this effect is not large enough to warrant 
compensation during targeting. 
2.4.3 Limitations 
One limitation of this work arises due to the fact that obtaining images at a suitable frame 
rate to capture the deformation occurring during rapid biopsy gun firing necessitates the 
use of 2D, rather than 3D, TRUS imaging. We are therefore able to quantify deformation 
in directions non-parallel to the 2D TRUS imaging plane only indirectly, in several ways. 
First, because the biopsy sequence images in this study were selected in part due to the 
presence of visible micro-calcifications for the purposes of quantifying the TRE and FLE, 
the visibility of such small structures in all three images in each sequence limits the out-
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of-plane tissue motion by a function of calcification size and ultrasound beam thickness. 
Second, the measured in-plane lateral dependence shown in Figure 2.10 suggests a bound 
on the out-of-plane deformation, under the assumption that it is similar to that which is 
observed within the 2D TRUS images. Finally, because we quantified the tissue 
deformation for a large number of biopsies (190) taken during clinical sessions, our in-
plane deformation quantifications are on a representative sampling of differently 
positioned and oriented prostate tissue cross sections imaged by 2D TRUS. 
We calculated the TRE using the fiducials located by a single observer over 
multiple days.  One limitation of this approach is that inter-observer variability in fiducial 
localization is not taken into account.  As a step toward assessing this limitation, a second 
observer located 64 fiducials of four patients five times on five different days.  The 
measured FLE of the second observer (0.09 mm) was similar to that of the first observer 
(0.12 mm), suggesting that inter-observer variability in fiducial localization may not be a 
dominant factor. 
In order to evaluate the tested registration algorithms and incorporate 
measurement error into our tissue deformation estimates, we computed a single TRE for 
each algorithm based on multiple fiducials localized in images of several patients.  This 
approach makes the assumption of a spatially uniform TRE that is invariant to differences 
between subjects.  Although it is theoretically possible to calculate a separate TRE for 
each subject, each biopsy sequence, and even (via TRE interpolation) each pixel of each 
registered image pair, such calculations require a sufficiently regular and dense 
distribution of intrinsic fiducials (calcifications) in every image in order to robustly 
estimate a spatially-varying TRE for every image pair.  With an average of 6.2 naturally 
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occurring calcifications appearing in each of our tested images, the robustness of an 
estimate of a spatially-varying TRE for each image is questionable.  This motivated the 
computation of an overall TRE based on 390 fiducials across multiple patients, under the 
above assumptions. 
Another limitation of this work concerns the assumption of the independence of 
uncertainties in Equation 2.4.  Since the TRE of a registration algorithm may have some 
effect on the standard deviation of the deformation vector fields that it produces, it could 
be argued that there may be some dependence between these uncertainties.  Since the 
strength of the independence assumption is unclear, it is reasonable to consider the effect 
on the results if this assumption is not made.  In this case, the upper bound on the total 
uncertainty is the ordinary sum of the individual uncertainties [16]; i.e., in our case, 
𝜎𝑟(𝑃) would become ?̃?𝑟(𝑃) + 𝑇𝑅𝐸.  Using this extremely conservative approach, we 
would observe a maximum value of 1.96𝜎1(𝑃𝑑
𝐴) = 2.3  mm, occurring at 𝑑 = 0, across 
both systems.  Consequently, spherical tumours with radius 2.3 mm or more could be 
sampled with 95% confidence, under the assumption of zero error elsewhere in the 
biopsy system. 
2.5 Conclusion 
In this work, we utilized deformation vector fields given by the symmetric forces 
Demons non-rigid image registration algorithm to quantify the deformation of prostate 
tissue that occurs during needle insertion and biopsy gun firing.  We computed the 
coherence of the tissue motion as well as the 95% confidence interval around the amount 
of tissue motion, incorporating the measurement error given by the TRE.  We calculated 
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these statistics in clinically relevant regions of the deformation vector fields in order to 
observe trends in the deformation as functions of the distances to the needle axis and 
lower piercing point.  We also decomposed the deformation and into its lateral and axial 
components, and computed the relationship of the deformation to the lateral position of 
the needle with respect to the prostate.  All of these measurements were used to compare 
the conventional hand held approach to a mechanically assisted biopsy system developed 
in our laboratory.  Overall, we observed a statistically significant, but clinically 
insignificant, maximum difference of 0.38 mm in the deformation resulting from the hand 
held and mechanically assisted systems along the needle axis.  The mechanical system 
resulted in a lower relative increase in deformation proximal to the needle axis during 
needle insertion, as well as lower variability of deformation during biopsy gun firing.  
The results show that for both systems, the tissue deformation is such that throughout the 
length of the needle axis, including regions proximal to the lower piercing point, 
spherical tumours with radius 2.1 mm or more can be sampled with 95% confidence, 
under the assumption of zero error elsewhere in the biopsy system.  Along the needle 
axis, the deformation was predominantly in the lateral direction; this is of particular 
importance given the long, narrow shape of the biopsy core.  We measured lateral tissue 
motion proximal to the needle axis of not more than 1.5 mm, with 95% confidence.  
There was a weak negative relationship between tissue deformation in a local region 
around the needle and the lateral position of the needle with respect to the prostate; the 
closer was the needle to the center of the prostate, the less was the observed deformation.  
Given the clinical need to biopsy tumours of volume greater than or equal to 0.5 cm3, 
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corresponding to spherical tumours of radius 5 mm or more, the tissue motion induced by 
needle insertion and gun firing contributes to the overall error of the biopsy system 
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Chapter 3. 
2D-3D rigid registration to compensate for prostate 
motion during 3D TRUS-guided biopsy 
 
3.1 Introduction 
With the aim of improving the cancer detection rate, systems have been developed [1, 2] 
that can plan and record biopsy locations in a 3D TRUS image acquired at the beginning 
of the biopsy procedure.  Although early reports of these systems are promising, some 
limitations have been identified that require attention [3].  For instance, patient motion 
and ultrasound probe pressure can cause the prostate to move and deform during the 
biopsy procedure.  In this chapter, we focus on improving the needle targeting accuracy 
of such systems by compensating for prostate motion during the procedure.  Target 
biopsy locations are usually identified with the assistance of an MR image acquired prior 
to the biopsy session, in which cancerous regions are more visible.  These locations are 
mapped to the 3D TRUS image acquired during the biopsy session to provide guidance 
using image information contained in the MR image.  The 3D TRUS image can then act 
as a baseline image, to guide the physician to the target biopsy locations by augmenting 
the 2D TRUS planes acquired during biopsy with 3D contextual information.  However, 
motion during the procedure could lead to a misalignment between the targets identified 
in the initially-acquired 3D image and their corresponding locations within the patient’s 
prostate as depicted by the real-time 2D TRUS images acquired throughout the biopsy 
procedure.  Compensating for the prostate motion and deformation by registering the pre-
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acquired 3D image to the live 2D images acquired throughout the procedure is an 
important step toward improving the targeting accuracy. 
Previous approaches to compensation for prostate motion during biopsy have 
involved mechanical stabilization of the ultrasound probe, 3D tracking of the probe, and 
the use of biplanar or 3D transducers to continuously acquire richer image information 
supporting software-based motion compensation algorithms [1-5].  The mechanically 
assisted 3D TRUS-guided biopsy system developed in our laboratory and described in 
detail in [1], uses a passive mechanical arm to track the position and orientation of the 
ultrasound probe during the biopsy procedure.  The design yields a remote centre of 
motion positioned at the centre of the ultrasound probe tip that provides enhanced 
stability to the US probe minimizing prostate motion.  Several methods have been 
proposed in similar 3D TRUS-guided biopsy systems to register real-time TRUS images 
during the procedure to an initially acquired 3D image [2, 4, 5].  The 3D TRUS-guided 
biopsy system presented in Xu et al. [2] uses a magnetic tracking method to locate the 
ultrasound plane and it then performs an intermittent rigid registration to compensate for 
out-of-plane prostate motion; the registration is invoked when misalignment is detected 
visually by an operator.  The magnetic tracker transform provides an initialization for the 
2D US plane within the world coordinate system in their system.  In that work, however, 
registration accuracy was measured with a phantom study.  Baumann et al. [5] presented 
a method relying on the simultaneous real-time acquisition of dual, orthogonal 2D TRUS 
images acquired from a 3D ultrasound probe.  The same authors presented an algorithm 
[4] to compensate for motion using 3D TRUS volumes acquired continuously throughout 
the biopsy session.  This system does not use any method to track ultrasound probe 
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motion; therefore, it relies only on the image information for tracking and uses a coarse-
to-fine image-based approach to limit the search space during optimization.  In addition, 
this approach requires a special 3D ultrasound probe with enhanced functionality that 
could simultaneously acquire orthogonal 2D TRUS planes and image acquisition occurs 
at a lower frame rate, compared to more conventional 2D TRUS.  Moreover, compared to 
2D TRUS images, orthogonal 2D planes deliver considerably more spatial information; 
registration of a single 2D TRUS plane to a 3D TRUS image is a more challenging 
problem. 
Previous work [6] has assessed the registration accuracy of several algorithms 
intended to register two intra-session 3D TRUS images.  Although the reported 
registration errors in [6] are within a clinically acceptable range, using this method within 
the clinical workflow would require stopping the procedure and acquiring an additional 
3D TRUS image each time prostate motion correction is required, leading to questionable 
feasibility of clinical implementation.  Registration of real-time 2D TRUS images to the 
pre-acquired 3D TRUS image enables motion compensation without adding extra 3D 
image-acquisition time (approximately a minute using 3D TRUS system in [1]) to the 
biopsy protocol, and without requiring the use of a 3D TRUS probe.  To the best of our 
knowledge, no previous work has described and evaluated on human clinical images a 
method for the registration of 2D TRUS to 3D TRUS images for prostate motion 
compensation during biopsy.  Such a technique, if properly validated, will make it 
possible to perform prostate motion compensation on 3D biopsy guidance systems that 
use readily available 2D ultrasound probes for live image acquisition throughout the 
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procedure, permitting more widespread use of targeted biopsy systems and thus greater 
potential impact on the patient population. 
2D-3D registration methods have been applied to several other interventional 
applications in image-guided procedures and Markelj et al. [7] contains an excellent 
review. Birkfellner et al. [8] compared the performance of several image similarity 
measures and optimization techniques for 2D-3D registration of fluoroscopic images and 
found that cross-correlation is an optimal metric for intra-modality matching.  In addition, 
the parallelizability of the computation of the cross-correlation metric in an intra-modal 
registration could be used improve the speed of execution to become useful in a clinical 
setting.  Wein et al. [9] presented a method to compensate for respiratory motion during 
abdominal biopsies and ablations under ultrasound guidance, optimizing local normalized 
cross-correlation using the Powell-Brent direction search technique.  Although these 
previous successes speak to the potential feasibility of addressing the issue of prostate 
motion compensation in software using a 2D-3D intensity-based image registration 
technique, prostate appearance on TRUS and motion characteristics during biopsy may 
differ from those of other organs due to different tissue stiffness properties and flexibility 
of surrounding anatomical structures.  In this work, our objective is to develop and 
evaluate a 2D TRUS-3D TRUS intensity-based image registration technique to 
compensate for prostate motion with sufficient accuracy and speed to be translated to 
clinical use for 3D biopsy guidance. 
This work describes three primary contributions: (1) We present an intensity-
based registration algorithm to register 3D TRUS images acquired at the start of the 
biopsy procedure to 2D TRUS images acquired during the procedure before the physician 
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fires the biopsy gun.  We evaluated the performance of the registration algorithm both in 
terms of accuracy and speed, after using a GPU-accelerated implementation.  The 
accuracy of the algorithm was measured using manually identified intrinsic fiducials 
within the prostate.  (2) We performed the registration for 2D TRUS images acquired 
every second throughout the biopsy procedure in order to evaluate registration accuracy 
in a scenario when prostate motion is compensated continuously using software, without 
requiring any human input to trigger the algorithm.  This continuous process was 
executed in parallel with other software providing the user interface and thus the 
continuous execution of this registration procedure was transparent to the user.  At every 
one-second interval, we incrementally transformed the baseline 3D TRUS image 
according to the registration obtained during the interval.  (3) We further validated the 
algorithm using a set of 3D TRUS images that were obtained with different levels of 
controlled probe pressure.  3D TRUS images were sampled to obtain representative 2D 
TRUS images with different amounts of prostate motion and deformation.  This data set 
contained images with intentionally introduced motion and deformation of magnitudes 
intended to challenge the algorithm.  In addition, the availability of the 3D information 
yielded more intrinsic fiducials for validation.  In this work, we also studied the 
correlation between image similarity metric values and the amount of misalignment in the 
prostate. 
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3.2 Materials and methods 
3.2.1 Data acquisition 
We acquired images from human clinical biopsy procedures using a mechanically 
assisted 3D TRUS-guided biopsy system [1] in a study approved by the Human Research 
Ethics Board of Western University.  The system, using a commercially available end-
firing 5-9 MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA), acquired 
a 3D TRUS image at the beginning of the biopsy procedure, and then acquired and 
displayed 2D TRUS images at a video frame rate (7-30 frames per second) during the 
biopsy session.  The mechanical encoders attached to the ultrasound probe tracked its 3D 
position and orientation throughout the procedure.  Using this system, we recorded 
images acquired during clinical biopsy procedures under two different protocols, in order 
to obtain data sets to test the robustness of the registration algorithm under different 
motion characteristics of the prostate.  For both protocols, all 3D TRUS images were 
recorded prior to taking any biopsy tissue samples.  For the first protocol (henceforth 
referred to as the biopsy protocol), we acquired images from eight patients.  Following 
the standard operating procedure for 3D TRUS-guided biopsy in our trial, a 3D TRUS 
image was acquired at the start of the biopsy procedure. From the sequence of images 
that followed at video frame rate (10-30 frames per second) during the procedure, we 
recorded live 2D TRUS images at one frame per second.  For the second protocol 
(henceforth referred to as the probe pressure protocol), images were acquired from ten 
patients.  3D TRUS images were acquired after applying three different probe pressures 
on the prostate gland centrally: 1) applying a medium probe pressure, similar to what the 
physician usually applies during a biopsy, 2) applying a low probe pressure that caused 
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minimal prostate displacement, and 3) applying a high probe pressure that caused 
substantial prostate deformation and anterior displacement.  This yielded a data set with 
prostate displacements and deformations under a wide range of ultrasound probe 
pressures. 
3.2.2 2D-3D registration – biopsy protocol 
For each of the eight subjects, we selected 1–3 2D TRUS images per patient 1–2 seconds 
prior to biopsy needle insertion from the 10-12 biopsy samples taken during the biopsy. 
This choice of 2D TRUS images was motivated by the fact that accurate alignment of the 
predefined targets with the intra-procedure anatomy is chiefly required immediately prior 
to biopsy, when a tissue sample is to be taken from an intended biopsy target. We 
analyzed 16 such images from eight patients.   
The transformation, 𝑇𝑇𝑟 ∶  𝛹 →  𝛺,  given by encoders on the joints of the linkage 
of the mechanical assisted 3D-TRUS biopsy system [1], maps each live 2D TRUS image, 
𝐼𝑙𝑖𝑣𝑒 ∶  𝛹 →  ℝ, to the world coordinate system of the previously acquired 3D TRUS 
image 𝐼𝑏𝑎𝑠𝑒 ∶  𝛺 →  ℝ, where 𝛹 ⊂  ℝ
2 and  𝛺 ⊂  ℝ3.  Within the 3D world coordinate 
system, any differences in prostate position and orientation between the real-time 2D 
TRUS images and the initially-acquired 3D TRUS image are due to prostate motion 
within the patient, gross movements of the patient during the procedure, and the biopsy 
system’s tracking errors.  The accuracy of the initialization for the prostate motion 
registration algorithm is based in part on tracking errors of the biopsy system.  In the 
system developed by Bax et al. [1], the accuracy in delivering a needle to a biopsy core in 
a phantom were found to be 1.51 ± 0.92 mm.  Registration of live 2D TRUS images to 
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the pre-acquired 3D image compensates for both the tracking errors and errors due to 
prostate and patient motion. 
 
Figure 3.1:2D-3D registration workflow  
The overall workflow in our method is depicted in Figure 3.1.  Using the 
mechanical tracker transform (𝑇𝑇𝑟) we transform 𝐼𝑙𝑖𝑣𝑒 to the 3D world coordinate system. 
Registration is then performed to 𝐼𝑏𝑎𝑠𝑒 within this coordinate system. To reduce the 
effects of speckle, anisotropic diffusion filtering [10] (conductance parameter = 2, time 
step = 0.625) of images was used as a pre-processing step.  Although there can be non-
rigid deformation of the prostate due to ultrasound probe pressure [6], a rigid alignment 
can be found with lower computational cost, so we investigated the accuracy of rigid 
registration in this work to determine whether rigid registration is sufficient for the 
clinical purpose of biopsy targeting.  For each 2D TRUS image, finding the 
corresponding plane in the pre-acquired 3D TRUS volume is a 2D-to-3D intra-modality 
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rigid registration problem.  Due to limited ultrasound contrast within the prostate, reliable 
extraction of the boundary and other anatomic features is challenging.  Therefore, we 
tested an intensity-based registration algorithm.  
Using the mechanical tracker transform 𝑇𝑇𝑟, we can position and orient the 2D 
TRUS image 𝐼𝑙𝑖𝑣𝑒 within the 3D world coordinate system yielding a 3D image 𝐼𝑙𝑖𝑣𝑒 as 
 𝐼𝑙𝑖𝑣𝑒(𝑇𝑇𝑟(𝑝1)) = 𝐼𝑙𝑖𝑣𝑒(𝑝1) where 𝑝1 ⊂  𝛹. 
The registration of the baseline 3D image 𝐼𝑏𝑎𝑠𝑒 to 𝐼𝑙𝑖𝑣𝑒 is performed in this 3D 
world coordinate system considering 𝐼𝑏𝑎𝑠𝑒 as the source image and 𝐼𝑙𝑖𝑣𝑒 as the target 
image.  The objective of the registration is to find the transformation, 𝑇 : 𝛺 →  𝛺, 
consisting of a six-parameter-vector given by  , that aligns anatomically homologous 
points in 𝐼𝑏𝑎𝑠𝑒 and 𝐼𝑙𝑖𝑣𝑒.  We used normalized cross-correlation (NCC) [11] as the image 
similarity metric that was optimized during the registration.  For two images 𝐼1 and 𝐼2, we 
optimized the objective function defined as: 
𝐹 =  argmax
 
𝑁𝐶𝐶(𝐼1, 𝐼2;  ), where  
𝑁𝐶𝐶(𝐼1, 𝐼2;  ) =
∑ (𝐼1̃(𝑝) − 𝐼
̅
1)(𝐼2(𝑇 (𝑝)) − 𝐼2̅)𝑝∈𝛺1,2
𝑇 
{(∑ (𝐼1(𝑝) − 𝐼1)
2
𝑝∈𝛺1,2
𝑇 ) (∑ (𝐼2(𝑇 (𝑝)) − 𝐼2̅)
2
𝑝∈𝛺1,2
𝑇 )}
1
2
 
(3.1) 
and  𝛺1 and 𝛺2 represent the subspaces of ( 𝛺 ⊂  ℝ
3) containing the image domains of 𝐼1 
and 𝐼2, i.e., Ω1,2
𝑇𝑢 = {𝑝 ∈  Ω1|𝑇 
−1(𝑝 ∈ Ω2)}. 
We optimized the image similarity measure given by 𝑁𝐶𝐶 (𝐼𝑙𝑖𝑣𝑒 , 𝐼𝑏𝑎𝑠𝑒) to obtain 
𝑇𝑢 for each of the 16 images we acquired.  We used Powell’s method [12, 13] to optimize 
the six-dimensional search space that includes three translations and three rotations. 
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Powell’s method improved the speed of execution, when compared with a gradient-
descent-based method during our initial experiments.  
3.2.3 Incremental 2D-3D registration for continuous intra-biopsy motion 
compensation 
The registration to compensate for prostate motion can be performed frequently (e.g., 
once per second) throughout the biopsy procedure, with the frequency of registration 
limited by the time required to register a single pair of images.  At a given time point 
denoted by 𝑡𝑛 (time elapsed in seconds from the start of the biopsy), we initialized the 
source image for the nth registration with the transformation matrix obtained from 
registrations at previous time points using  
𝑇 = ∏ 𝑇 𝒕
𝑡𝑛
𝑡=𝑡0
, (3.2) 
 During the nth registration, we found the parameter vector  𝒕𝒏 that gave the optimum 
𝑁𝐶𝐶 measure for the transformation matrix 𝑇 𝒕𝒏 . We performed the registration for the 
complete biopsy procedure for the eight patients described in the previous section using 
the sequence of live 2D TRUS images recorded every second from the start of the biopsy 
procedure. 
3.2.4 2D-3D registration – probe pressure protocol 
3D TRUS images acquired at different probe pressures can provide additional anatomical 
context to enhance the validation of our registration algorithm.  We denote images 
acquired at low, medium and high probe pressures, respectively, as 𝐼𝑙𝑜𝑤 , 𝐼𝑚𝑒𝑑 , 𝐼ℎ𝑖𝑔ℎ: 𝛺 →
 ℝ.  We acquired 30 such images from 10 patients. 
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We set the image acquired at medium pressure, 𝐼𝑚𝑒𝑑, as the source image.  As our 
target image, we selected 2D slices (𝐼{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}) from the 3D images 𝐼𝑙𝑜𝑤 and 𝐼ℎ𝑖𝑔ℎ.  For 
the 20 registrations performed (using the 30 3D TRUS images) mechanical tracker 
transformations (𝑇𝑇𝑟) were randomly selected from 16 frames (across 8 subjects in the 
biopsy protocol) occurring an average of 1-2 seconds prior to the firing of the biopsy gun 
in real biopsy procedures, according to 𝐼{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}(𝑝2) = 𝐼{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}(𝑇𝑇𝑟(𝑝1))  where 𝑝1 ⊂
 𝛹 and 𝑝2 ⊂  𝛺. 
Hence, the target images are representative of live 2D TRUS images depicting a 
situation with minimal prostate motion (slice from 𝐼𝑙𝑜𝑤) and substantial prostate motion 
(slice from 𝐼ℎ𝑖𝑔ℎ).  Since the physician intentionally applies different levels of pressure 
during the acquisition, the set of images contains a wide range of prostate displacements 
and deformations that are intended to represent the extremes of probe pressure during the 
biopsy procedure to challenge the registration algorithm.  For each subject, we perform 
registration between images 𝐼𝑚𝑒𝑑-𝐼𝑙𝑜𝑤 and 𝐼𝑚𝑒𝑑-𝐼ℎ𝑖𝑔ℎ by respectively optimizing the 
image similarity measures, 𝑁𝐶𝐶(𝐼𝑙𝑜𝑤, 𝐼𝑚𝑒𝑑) and 𝑁𝐶𝐶(𝐼ℎ𝑖𝑔ℎ, 𝐼𝑚𝑒𝑑) as defined above in 
Equation 3.1. 
3.2.5 Validation  
3.2.5.1 Biopsy protocol registration 
The registration was validated using manually-identified corresponding intrinsic fiducial 
pairs (micro-calcifications) [6].  For the images acquired under the biopsy protocol, 
fiducials appearing in 𝐼𝑏𝑎𝑠𝑒, denoted by 𝑓𝑏𝑎𝑠𝑒, and the corresponding fiducials from 𝐼𝑙𝑖𝑣𝑒, 
denoted by 𝑓𝑙𝑖𝑣𝑒, were identified (𝑓𝑙𝑖𝑣𝑒  ⊂  𝛹 and  𝑓𝑏𝑎𝑠𝑒  ⊂  𝛺).  We identified 52 fiducial 
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pairs for 16 biopsies in eight patients.  These fiducial pairs were used for validation only 
and were not provided as input to the registration algorithm.  Fiducial localization error 
(FLE) has been reported in previous studies in the context of 3D TRUS and 2D TRUS 
images.  The FLE in 3D TRUS images was reported to be 0.21 mm [6] and in 2D TRUS 
images was 0.11 [14] mm.  The target registration error was calculated as the root mean 
square (RMS) error 
𝑇𝑅𝐸𝑏 =
√∑ (𝑇𝑇𝑟
−1(𝑓𝑙𝑖𝑣𝑒
𝑘)− 𝑇 
𝑏(𝑓𝑏𝑎𝑠𝑒
𝑘))
2𝑁𝑘
𝑘=1
𝑁𝑘
, 
(3.3) 
 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 = √
∑ 𝑇𝑅𝐸𝑏
2𝑁𝑏
𝑏=1
𝑁𝑏
  , 
(3.4) 
where 𝑁𝑏 is the number of biopsies and 𝑁𝑘 is the number of fiducials identified for a 
particular pair of images. The TRE was estimated by first calculating RMS values 𝑇𝑅𝐸𝑏 
using the fiducials identified in each pair of images for each biopsy and then calculating 
the RMS value 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 for the number of biopsies performed.  This approach averaged 
the contributions to the TRE from the variable number of fiducials manually identified in 
each pair of images during a biopsy.  The pre-registration error was calculated without 
applying the registration transform 𝑇  in Equation 3.3 to compare against TRE post 
registration to assess the improvement. 
We selected images that contained visible micro-calcifications within the prostate 
in calculating 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦; an ideal registration algorithm would bring these homologous 
landmarks into alignment after registration.  Although the fiducials are small (less than 
~1 mm radius) by comparison to the size of the prostate and field of view (Figure 3.2 
depicts some sample fiducials that we identified), in principle it is possible that the 
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presence of the calcifications could guide an intensity-based registration algorithm to a 
result giving a lower 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 than would be obtained if the fiducials were not present 
in the images.  In order to test if the presence of micro-calcifications drive the registration 
algorithm to a more accurate solution, we defined masks over the identified fiducials in 
both the target and source images and performed the registrations described in the biopsy 
protocol registration, restricting the calculation of the image similarity metric to regions 
outside of the masks; i.e., to regions not containing the fiducials.  Thus, in this 
experiment, the registration algorithm was blinded to the presence and locations of the 
fiducials.  The masks were defined as spherical regions with 1 mm radius in order to fully 
cover the largest fiducial markers we observed in our data set. 
 
Figure 3.2: Sample fiducials identified. 
3.2.5.2 Probe pressure protocol registration 
In the data set acquired under the probe pressure protocol, full 3D anatomical information 
for the whole prostate was available for both the source and target images.  We manually 
identified 188 fiducials throughout the 3D volumes obtained from 10 subjects, without 
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limiting the fiducials to lie within the particular extracted plane used in the registration.  
The TRE was computed as 
𝑇𝑅𝐸𝑝 =
√∑ (𝑇3𝐷−𝑤𝑜𝑟𝑙𝑑(𝑓𝑚𝑒𝑑
𝑘)− 𝑇𝑢
𝑏(𝑓{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}
𝑘))
2𝑁𝑘
𝑘=1
𝑁𝑘
, 
(3.5) 
 𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = √
∑ 𝑇𝑅𝐸𝑝
2𝑁𝑝
𝑏=1
𝑁𝑝
  , (3.6) 
where 𝑓{𝑚𝑒𝑑,𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}  ⊂  𝛺  are the fiducials identified in  𝐼𝑚𝑒𝑑, 𝐼𝑙𝑜𝑤, 𝐼ℎ𝑖𝑔ℎ. 
We also computed the optimal rigid alignment using the identified fiducials to 
define the rigid transformation that yielded the minimum TRE for the given fiducials per 
patient.  To do this, we found the fiducial registration error (FRE) [15] for each set of 
fiducial pairs in each patient, after transforming the fiducials with the parameters 
corresponding to the best rigid alignment.  With the presence of non-rigid deformations 
in the probe pressure protocol data set, the FRE gives a lower bound on the 𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
that can be obtained using a rigid registration.  In a sense, the FRE gives an indication of 
the amount of non-rigid deformation present in the data set; e.g., an FRE of 0 mm would 
indicate that a rigid transformation could fully compensate for the observed changes in 
the prostate, and an FRE > 0 mm would indicate that some amount of non-rigid 
deformation may have occurred in the prostate.  Thus the FRE gives some indication of a 
“best-case” TRE that could be obtained from a registration algorithm using a rigid 
transformation and it is therefore of interest to compare the FRE to the 𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
obtained from our registration algorithm. 
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We used the fiducials throughout the prostate to calculate the TRE.  To test 
whether the TRE varies with distance to the registration plane, we plotted TRE against 
the distance to the registration plane for each fiducial. 
3.2.6 GPU implementation 
The step consuming the most computation time during execution of the registration was 
the calculation of the image similarity metric during optimization.  Therefore, we 
implemented the 𝑁𝐶𝐶 calculation on an nVidia GTX 690 (Nvidia Corporation, Santa 
Clara, CA) graphics processing unit (GPU) using compute unified device architecture 
(CUDA) C++.  The normalized cross-correlation calculation is inherently parallelizable.  
Instead of using a sequential approach to transform each voxel independently, we 
transformed all voxels in the moving image in parallel during each iteration of 
optimization.  These transformations were followed by 3D linear interpolation of image 
intensities to resample the moving image that was also performed within the GPU.  The 
subsequent calculation of the summations in Equation 3.1 was also done in parallel to 
further accelerate the execution. 
3.2.7 Correlation between image similarity metric and misalignment 
During registration, we optimize an image similarity metric over a 3D transformation 
space.  The relationship between the image similarity metric and the amount of 
misalignment not only conveys the suitability of the metric to be used in registration, but 
also it shows whether the image-similarity metric could be used as an indicator of the 
misalignment.  This could be a useful feature to trigger the registration algorithm in a 
system that does not continuously compensate for motion as during biopsy.  To analyze 
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this relationship using the biopsy protocol data, we plotted the calculated normalized 
cross-correlation measures for each instance before registration, during registration (for 
each iteration during the optimization) and after registration (after the optimizer 
converged) and their corresponding 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 values. 
With manually identified fiducials, we should be able to find a plane within the 
3D TRUS image that yields zero (or near zero) TRE.  We analyzed the behaviour of 
normalized cross-correlation near this “optimum” plane by extracting 2D images lying 
nearby (in terms of the six parameters,  , defining 3D translation and rotation) planes in 
the 3D TRUS image, and computed the image similarity metric for the 2D TRUS image 
and these nearby 2D images from the 3D TRUS image.  Although this approach does not 
fully explore the six-dimensional objective function, to simplify the visualization of the 
results, we analyzed the metrics by varying one degree-of-freedom at a time. 
3.2.8 TRE as a function of distance to the probe tip 
We analyzed the TRE as a function of distance of each fiducial to the ultrasound probe 
tip, to test if the registration error is larger within the regions of the prostate close to the 
ultrasound probe.  Since we used a rigid transformation during registration, non-rigid 
deformation of the prostate would be reflected as part of the TRE.  Ultrasound probe 
pressure might cause inconsistent deformation in different regions of the prostate, which 
could lead to regionally-varying accuracy of motion compensation by a rigid 
transformation.  
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3.3 Results 
3.3.1 Validation: biopsy protocol data 
The 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 was calculated according to Equation 3.4 and its RMS±std. was found to 
be 1.87 ± 0.81 mm, after manually localising 52 fiducial pairs over 8 patients.  This was 
an improvement over 4.75 ± 2.62 mm before registration.  Since these TRE distributions 
were found to be not normally distributed using one-sample Kolmogorov-Smirnov test 
with a significance level p < 0.0001, we tested the null hypothesis that their medians were 
equal with a non-parametric test using Prism 5.04 (Graphpad Software Inc., San Diego, 
USA).  The Wilcoxon signed rank matched pairs test rejected the null hypothesis (p < 
0.0001) suggesting that there is a statistically significant difference in TREs before and 
after registration.  When the registrations were performed with the fiducials masked out, 
the TRE was found to be 1.93 ± 0.66 mm.  When compared with the distribution of 
𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦, the Wilcoxon signed rank matched pairs test failed to reject the null 
hypothesis (p = 0.74).  Thus, we were unable to detect a statistically significant difference 
between the TREs resulting from registrations where the fiducials were present and 
registrations where the fiducials were absent. 
When 2D-3D registration was performed incrementally every second during the 
biopsy, the RMS ± std TRE was reduced to 1.63 ± 0.51 mm.  The mean number of 
iterations required for convergence decreased from 5.6 to 2.75.  Figure 3.3 shows 
changes in TRE values before registration, after registration and after registering the 
frame obtained every second for each biopsy taken.  Figure 3.4 contains two 
representative example images, depicting the visual alignment qualitatively for 
registration just prior to biopsy.  The post-registration TRE of these two example images 
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were found to be 1.5 mm (top row) and 1.2 mm (bottom row), which had improvements 
from 3.7 mm (top row) and 5.3 mm (bottom row) before registration.  Grid lines overlaid 
at corresponding locations in image space facilitate visual evaluation of the alignment of 
the anatomy pre- and post-registration. 
 
Figure 3.3: TRE before registration, after registration and after continuous registration every second for 
each biopsy in prostate biopsy protocol.  
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Figure 3.4: Images before and after registration immediately prior to taking a biopsy sample. Left column: 
Real-time 2D TRUS images. Middle column: Corresponding images before registration assuming no 
prostate motion (from the transformation given by the mechanical tracking system). Right column:  
Corresponding images after registration.   
  
Figure 3.5: TRE as a function of time elapsed from the start of the biopsy. (a) TRE before registration.  (b) 
TRE after registration. (c) TRE after registering the images acquired every second.  
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TRE values before and after registration have an increasing trend with the elapsed time 
during the biopsy.  Weak relationships were found with slopes of the best-fit line 10 µm/s 
(correlation coefficient (r2) = 0.23) before registration and 4 µm/s (r2 = 0.41) after 
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was found to be 2 µm/s (r2 = 0.37).  We also calculated the slopes of the best-fit lines to 
plots of TRE versus time elapsed during biopsy for each individual patient, and then 
calculated the mean and standard deviation of these observed slopes in scenarios with and 
without the use of motion-compensating registration.  Without registration, we observed 
a mean±std slope of 14±15 µm/s.  With registration, we observed a mean ± std slope of 
7±10 µm/s, and 5±14 µm/s with continuous registration.  
3.3.2 Validation: probe pressure protocol data 
The RMS TRE for the data acquired under the probe pressure protocol was 3.18 ± 1.6 
mm.  This was an improvement from a 6.89 ± 4.1 mm TRE before registration.  Note that 
we used the fiducials in the whole prostate (not just the slice containing the fiducials) in 
TRE calculation as given in Equation 3.6.  The mean value for the FRE, corresponding to 
the best rigid transform that aligns the identified fiducials, was found to be 1.85 ± 1.2 
mm.  The distribution of TRE values before registration, after registration, and after 
transforming with the best rigid alignment is shown in Figure 3.6.  Table 3.1 contains 
TRE calculated separately for 𝐼𝑚𝑒𝑑-to-𝐼ℎ𝑖𝑔ℎ and 𝐼𝑚𝑒𝑑-to-𝐼𝑙𝑜𝑤.  Registration between  𝐼𝑚𝑒𝑑 
and 𝐼ℎ𝑖𝑔ℎ has resulted in a larger TRE.  We also observed higher FRE in 𝐼𝑚𝑒𝑑-to-𝐼ℎ𝑖𝑔ℎ, 
suggesting a greater amount of non-rigid deformation of the prostate at this extremum of 
probe pressure.  The error in registration includes the errors due to non-rigid deformation 
occurring within prostate regions outside of the 2D target image (as opposed to the errors 
arising only due to deformation within the 2D target image as in the biopsy protocol) and 
the variability in manually locating the fiducials in 3D.  However, according to the 
relationship between distance from registration plane to each fiducial and the TRE shown 
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in Figure 3.7, we did not observe a strong relationship between the TRE and the distance 
from registration plane to the fiducial. 
 
Figure 3.6: Histograms for TRE before and after registration for probe pressure protocol data.  Left: TRE 
distribution before registration Middle: TRE distribution after registration. Right: TRE distribution with the 
best rigid alignment for the identified fiducials. 
Table 3.1: Errors before and after probe protocol registration. 
 Error before registration 
(mm) 
TRE after registration 
(mm) 
FRE (mm) 
𝐼𝑚𝑒𝑑-to-𝐼ℎ𝑖𝑔ℎ 7.57 ± 4.58 3.65 ± 2.12 2.12 ± 1.45 
𝐼𝑚𝑒𝑑-to-𝐼𝑙𝑜𝑤  6.12 ± 3.68 2.65 ± 0.34 1.54 ± 0.68 
Average 6.89 ± 4.12 3.17 ± 1.60 1.85 ± 1.67 
 
Figure 3.7: TRE of each fiducial as a function of distance to the registration plane.  The black line 
represents the least-square fit to the scattered points. 
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3.3.3 Speed of execution 
After the GPU-accelerated implementation (nVidia GTX 690 GPU card and Intel Core 
i7-3820 3.6 GHz processor) the registration was performed with mean ± std times of 1.1 
± 0.1 seconds for the biopsy protocol experiments described in this paper. 
 
Figure 3.8: TRE as a function of metric value during the optimization. Initial points (circles), converged 
(squares) and converging points (crosses).   
 
Figure 3.9: TRE distributions before registration, during convergence and after registration.   
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points show the values before registration, and the square points show the values after 
registration converged.  The cross points depict the values during convergence.  The 
correlation coefficient (r2), calculated using all points (before, during, and after 
convergence) in Figure 3.8, was found to be 0.23.  Figure 3.9 shows a box plot of the 
TRE distributions of the points before registration, during convergence and after 
registration.  While the TRE decreases in general during convergence, a weak correlation 
can be seen between image similarity measures and TRE from these results. 
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Figure 3.10: Mean and standard deviations of normalized cross-correlation values for 16 image pairs of 
eight patients in the six-degrees-of-freedom transformation space, one degree-of-freedom varying at a time.  
The zero location in the x-axis corresponds to real-time 2D-TRUS frame. 
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Figure 3.11: Normalized cross-correlation values for a single image pair of a biopsy for 3 patients (each 
biopsy represented by a separate line pattern) in the six-degrees-of-freedom transformation space, one 
degree-of-freedom varying at a time.  The zero location in the x-axis corresponds to real-time 2D-TRUS 
frame. 
Figure 3.10 shows plots of the normalized cross-correlation metric versus out-of-
plane, in-plane rotations and translations. The solid curves represent the mean values of 
the metrics for different out-of-plane rotations and translations for 16 2D TRUS images 
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across eight subjects, and the dashed curves show the values one standard deviation 
above and below the mean.   The convexity of the mean curves gives an indication of the 
general capture range of the objective functions for many registrations.  Figure 3.11 
shows the three plots of normalized-cross-correlation metrics similarly obtained for a 
single biopsy in three patients.  The generally convex shape of the functions observed in 
Figure 3.10 and Figure 3.11 encourages the use of normalized cross-correlation during 
registration in compensating for prostate motion. 
3.3.5 TRE as a function of distance to the probe tip 
Figure 3.12 shows TRE as a function of the distance to the probe tip for each individual.  
The TRE tends to increase closer to the probe tip (r2 value = 0.1); however, the 
correlation between distance to the probe tip and the TRE before registration is weak.   
 
Figure 3.12: TRE as a function of distance to the probe tip. 
3.4 Discussion 
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TRE after registration in both biopsy and probe pressure protocols.  The required 
accuracy of the biopsy system to guide needles to target locations stems from the size of 
the smallest clinically-relevant tumours (0.5 cm3, corresponding to a spherical target with 
5 mm radius) [16, 17].  A biopsy system with a measured RMS error of 2.5 mm in taking 
a sample from the intended target will have a probability of at least 95.4% of taking a 
sample within this 5 mm radius since 5 mm is 2 standard deviations away from the mean 
of the distribution of targets given by an system with RMS error of 2.5 mm [6].  An 
image-based registration during the procedure, while compensating for prostate motion, 
also corrects for tracking errors in the biopsy system, if any.  Therefore, if the registration 
was performed immediately before the physician fires the biopsy gun to capture a tissue 
sample from the prostate, the targets identified in the pre-acquired 3D image would be 
aligned with the live 2D TRUS image, with accuracy limited by the TRE of the 
registration algorithm.  However, the motion and deformation induced due to the rapid 
firing of the biopsy gun, which happens during a sub-second interval remains an error in 
the biopsy system that is challenging to correct.  When targeting a predefined location, 
the TRE of the motion compensation algorithm and the error during the rapid biopsy-gun 
firing process, which was quantified in [14] to be an error with 95% confidence interval 
less than 2.1 mm, may accumulate and become an important consideration. 
Alignment of the targets identified in the 3D TRUS image to the live 2D TRUS 
image is primarily required immediately before the physician fires the biopsy gun.  
Consequently, this registration could be integrated into the clinical workflow by 
executing it just prior to the physician aiming at target locations.  However, according to 
the results, both the accuracy and speed of the registration were improved when the 
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registration was performed on the 2D TRUS images acquired every second.  
Initializations obtained by placing 2D TRUS images within the 3D coordinate system 
using the mechanical tracker transform (𝑇𝑇𝑟) might further improve when the baseline 3D 
TRUS image is updated more frequently with the transforms from registrations 
performed every second.  This may help the algorithm in faster convergence to a suitably 
accurate optimum.  Therefore, in a clinical procedure, this algorithm can be performed in 
the background continuously compensating for motion. 
3.4.2 Change of TRE with time during biopsy 
The weak positive relationship between TRE and time elapsed shown in Figure 3.5(a), 
suggest that the misalignment between pre-acquired and live images increases with time 
(slope of the best-fit line = 10 µm/s, mean±std = 14±15 µm/s for individual patients).  
After performing the registration just before a biopsy sample is taken, there is still a 
positive relationship (slope = 4 µm/s, mean±std = 7±10 µm/s) between TRE and time.  
This indicates that image pairs, with higher initial misalignments towards the end of the 
biopsy procedure, were more challenging for the algorithm.  In Figure 3.5(c), the slope of 
the best-fit line was lower (slope = 2 µm/s, mean±std = 5±14 µm/s) when the 
registrations were performed every second.  Thus, although the TRE does appear to 
increase with time even when registration is applied, this effect is less pronounced 
compared to the no-registration scenario.  The increasing trend in TRE with time that we 
observe for eight patients in Figure 3.5(c) even when the motion was being compensated 
every second could be due to accumulation of registration errors during continuous 
registration. In addition, the swelling and deformation of the prostate caused by the 
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increasing number of needles being inserted might increase the challenge to the algorithm 
as a function of time elapsed since the start of the biopsy. 
3.4.3 Probe pressure protocol 
The TREs from the probe pressure protocol are surrogate measures of the absolute total 
registration error that could be observed under extreme prostate deformations during 
prostate biopsy.  In probe pressure protocol, the TRE was 1.2 mm higher than that of the 
biopsy protocol.  This increase could be attributed to the use of fiducials from the whole 
prostate during validation.  The best rigid transform for the selected plane may not 
necessarily be the best rigid fit for the whole prostate due to non-rigid deformations 
occurring at different (out of plane) regions of the prostate.  Moreover, the high probe 
pressures intentionally exerted by the physician when acquiring these images might have 
caused more than the usual deformation that occurs during biopsy.  The extreme range of 
probe pressures and prostate displacement and deformation could make accurate 
registration more challenging as the algorithm is more susceptible to local optima the 
further the initialization is from target alignment.  In addition, substantial non-rigid 
deformation may result in higher TREs from rigid registration algorithms when high 
probe pressure is applied to the prostate.  Whereas the prostate deformations occurring 
during the biopsy protocol arise from real clinical biopsy sessions, the probe pressure 
protocol was explicitly designed to test the performance of the algorithm at the extrema 
of non-rigid deformations that can be reasonably applied to the patient's prostate in vivo, 
without consideration of the plausibility of such deformations occurring in a clinical 
biopsy context.  The outliers observed in Figure 3.6(c) suggest that a non-rigid 
transformation may be useful in correcting for the more extreme deformations applied 
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during the probe pressure protocol. This is illustrated quantitatively in the FRE column of 
the first row of Table 3.1, where registration errors involving high probe pressure were 
separately analyzed.  However, the fiducial identification process was relatively more 
straightforward due to the availability of 3D contextual information in both the fixed and 
moving images. 
3.4.4 Correlation between similarity metric and TRE 
Figure 3.8 shows a weak correlation between similarity metric values before, during and 
after convergence and the TRE.  We can observe for the cases where the metric values 
were greater than -0.9, the TREs were greater than 3.5 mm. Furthermore, the generally 
convex shapes observed in Figure 3.10 and Figure 3.11 in metric values as a function of 
different amounts of introduced translations and rotations, suggest that the metric value 
could be used as a weak indicator to the quality of the registration. 
In Figure 3.12, a weak negative correlation can be seen between the TRE and 
distance to the probe tip.  This suggests that near the probe tip there could be higher non-
rigid deformation of the prostate that may not be accurately compensated with a rigid 
registration algorithm. However, given the limited sample size and the weak relationship 
observed, further verification is required to attribute the negative correlation to the 
presence of non-rigid deformation. 
3.5 Conclusions 
Accurate and quick registration to compensate for motion during biopsy is an important 
step to improve the accuracy in delivering needle to target locations within the prostate.  
We presented a 2D-to-3D rigid intensity-based registration algorithm validated on human 
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clinical images using intrinsic fiducial markers, to align a 3D TRUS image (with 
associated prostate biopsy targets) acquired at the start of the procedure to 2D TRUS 
images taken immediately prior to each biopsy during the procedure.  We also presented 
evidence that image similarity metrics can be used as a weak indicator of the amount of 
prostate misalignment (with respect to the initially acquired 3D TRUS image), and could 
be used to trigger the execution of a registration algorithm when necessary.  Using our 
high-speed GPU implementation (1.1 seconds total time per registration), this algorithm 
has the potential to be useful during the clinical workflow of a biopsy procedure.   
Although 2D-3D registration methods described in this paper yielded statistically 
significant improvements in accuracy, the RMS TRE was found to be 3.18 ± 1.6 mm with 
the 3D TRUS data set acquired under a more controlled range of probe pressures 
intending to thoroughly test the algorithm,  Therefore, achieving a more accurate and 
robust registration for motion compensation could be helpful to meet the clinical 
requirements of accurately targeting smallest clinically significant tumors using 3D 
TRUS-guided biopsy systems.     
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Chapter 4. 
Evaluating the utility of intra-procedural 3D TRUS image 
information in guiding registration for motion compensation 
during prostate biopsy 
 
4.1 Introduction 
 With the objective of improving the cancer detection rate during biopsy, systems have been 
developed to perform a targeted biopsy by fusing pre-biopsy MRI with 3D TRUS [1-6].  In many 
such systems, prior to performing biopsy, suspicious lesions delineated as targets in a pre-biopsy 
MR image are mapped to the static baseline 3D TRUS image acquired at the beginning of the 
biopsy session [7-10].  Biopsy is subsequently performed, targeting each suspicious lesion using 
the live 2D TRUS images acquired while tracking the ultrasound probe position and orientation 
relative to the baseline 3D TRUS image.  However, patient or prostate motion during the 
procedure causes misalignments in the targets mapped to the live 2D TRUS images from the 
baseline 3D TRUS image. 
While 2D TRUS images are widely used for intra-procedural guidance, some solutions 
utilize richer intra-procedural images such as bi- or multi-planar TRUS or 3D TRUS, acquired 
by specialized probes.  Multiple algorithms have been proposed to perform software-based 
motion compensation by registering intra-procedural TRUS images to an initially acquired 3D 
TRUS image [1, 2, 5, 11].  However, intra-procedural image acquisition and initialization within 
the 3D coordinate system prior to registration are quite different in each method.  The system 
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proposed in Baumann et al. [1] used a GE Voluson endorectal RIC5-9 probe (GE Healthcare, 
United States) to acquire 3D intra-procedural images to perform image-based tracking to 
compensate for motion.  The 3D intra-procedural image acquisition time in that system was 
reported to be 0.5-5 s depending on the image quality while the subsequent non-rigid registration 
consumed an additional 7-8 s.  In Baumann et al. [2], the authors described a similar registration 
approach using simultaneously acquired dual-orthogonal frames from a 3D TRUS probe as the 
intra-procedural images.  Xu et al. [5] performed the registration after initializing several 
previous 2D TRUS frames in a 3D coordinate system using the transformations provided by a 
magnetically tracked probe.  In that system, 2D TRUS frames were acquired using a Philips C9-
5 2D TRUS probe (Philips Medical Systems, Seattle, WA) in real-time while the motion 
compensation algorithm, with an approximate execution time of 4 seconds, was triggered by the 
operator after visual detection of misalignment.  De Silva et al. [11] previously performed a 2D-
3D registration using the initialization provided by a mechanically tracked probe.  The 
registration was performed in 1.1 seconds following the real-time acquisition of the intra-
procedural image using the same conventional 2D TRUS probe (Philips Medical Systems, 
Seattle, WA) as in Xu et al. [5].  Both of the systems [5, 11] constructed the baseline 3D TRUS 
image at the beginning of the procedure using the 2D images acquired from a ~10 second 
rotational sweep of a tracked 2D TRUS probe.  In addition, intra-procedure prostate motion has 
been identified as a potential problem [12] hindering accurate needle targeting in MR-guided 
prostate biopsy systems [13-15].  Solutions [16, 17] have been proposed for motion 
compensation by co-registering multi-slice intra-procedural MR images with a pre-acquired MR 
image.     
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Live intra-procedural images acquired during the biopsy procedure need to be registered 
both quickly and accurately to compensate for motion.  During registration, we optimize an 
image-based similarity metric between pre- and intra-procedural images in a rigid 3D 
transformation space.  Although prostate deformation due to TRUS probe pressure could be 
compensated by a non-rigid registration approach, it is less desirable considering the slower 
speed of non-rigid registration in the context of the short duration of the biopsy procedure and 
the limited time of effect of the local anesthesia provided to the patient. In addition, achieving a 
robust rigid registration is an essential initial step before proceeding to a non-rigid refinement.  
Limited anatomical context available in single plane 2D TRUS images could limit the robustness 
of the registration, especially considering the rotational symmetry of the prostate, as there can be 
multiple ways (i.e., local optima) to orient a single 2D TRUS image within the 3D context that 
yield high image similarity values. On the other hand, intra-procedural 3D information in multi-
planar or 3D TRUS images provides richer anatomical context than in single plane 2D TRUS; 
this could help to improve the accuracy of the registration algorithm.  Therefore, by including 
additional 3D image planes in the image-similarity metric calculation, the objective function 
shape could change due to the additional (or “richer”) anatomical information, in order to 
improve the robustness of the optimizer in finding the desired registration solution.  However, 
both image acquisition and image registration require additional time when using intra-procedure 
3D information.  Multi-planar or 3D TRUS image acquisition either using probes with enhanced 
functionality or via multiple acquisitions by a rotational sweep of a tracked conventional 2D 
TRUS probe is slower than that using a near real time conventional 2D TRUS probe.  Moreover, 
image registration requires more time when using intra-procedural 3D TRUS images to calculate 
the image similarity metric values using more intensity samples. 
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In order to design a suitable approach to compensate for prostate motion, taking into 
account these tradeoffs between accuracy and speed, it is useful to quantify the improvements in 
registration accuracy obtained by acquiring different amounts of 3D information in the intra-
procedural TRUS images.  In this work, (1) we compared the motion compensation accuracies 
resulting from the use of several potential intra-procedural imaging approaches, ranging from 
single 2D TRUS frames to full 3D TRUS imaging, to evaluate how different amounts of 3D 
image information affect the registration accuracy; (2) we analysed how frequently and in which 
anatomic regions of the prostate the motion compensation accuracy benefits most from 
additional 3D image information acquired during the procedure; and (3) we investigated whether 
rigid alignments obtained via image-based registration could achieve accuracies suitable for use 
in a clinical setting. Our results could inform the designers of next-generation guided prostate 
biopsy systems as to (1) optimal design/selection of ultrasound imaging techniques to be used 
intra-procedurally; (2) whether and how to adaptively acquire additional 3D information when 
the physician is targeting specific regions of the prostate; and (3) whether to invest effort in the 
development of real-time non-rigid registration for prostate motion compensation during the 
procedure. 
4.2 Materials and methods 
4.2.1 Materials 
29 patients (mean ± std age: 59 ± 7, PSA: 5.4 ± 2.8 ng/ml, prostate volume: 38.8 ± 20.0 cm3) 
were included in this study that was part of a larger human subjects research ethics board 
approved MRI-3D TRUS fusion biopsy study. The 3D TRUS images were collected in advance 
of the scheduled biopsy as part of our institution’s standard protocol to fuse MRI to pre-biopsy 
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3D TRUS images.  3D TRUS images were acquired with a mechanically tracked 3D TRUS-
guided biopsy system described in Bax et al. [3], using a commercially available end-firing 5-9 
MHz HDI 5000 TRUS transducer probe (Philips Medical Systems, Seattle, WA).  During 3D 
TRUS image reconstruction, a set of 2D TRUS images was acquired by a 180 degree probe-axial 
rotation of the otherwise stationary TRUS probe (i.e., the entire probe is rotated, including its 
outer surface) and then resampled the resulting 2D planes in a 3D grid to obtain the 3D TRUS 
image.  Each 3D TRUS volume had a grid size of 224 × 224 × 175 voxels, with an isotropic 
voxel size of 0.37 mm, and was preprocessed via anisotropic diffusion filtering [18] 
(conductance parameter = 2, time step = 0.625) for speckle reduction.  Each 3D TRUS image 
acquisition required approximately 10 seconds. 
 
Figure 4.1: (a) Coronal view (from the posterior perspective of the TRUS probe) of relative positions of the probe 
tip during image acquisition (B: baseline, 1-6: sextant locations) (b) Transverse view showing the necessary 
reorientation of the probe to acquire images at baseline and targets 2 and 5. 
 
A total of 7 3D TRUS volumes were acquired per patient, with the first image acquired 
centrally within the gland—corresponding to the typical baseline 3D TRUS image acquired at 
the start of most MRI-TRUS fusion biopsy procedures [5, 11]. The six additional 3D TRUS 
images were acquired after maneuvering the TRUS probe toward each of the sextant biopsy 
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locations.  Figure 4.1 shows the relative bilateral sextant biopsy locations in the base, mid-gland 
and apex regions of the prostate when acquiring 3D TRUS images by a rotational sweep of the 
TRUS probe at each position.  The order of sextant 3D TRUS acquisitions was reversed for half 
of the patients (the order from 1 to 6 were reversed to 6 to 1 according to the positions shown in 
Figure 4.1) in an effort to mitigate possible dependence of prostate motion at each sextant 
location to the previous probe position. 
Each sextant 3D TRUS image comprises a set of 2D TRUS images that could be acquired 
using a conventional 2D TRUS probe when targeting a region in that sextant.  The mechanical 
encoders attached to the ultrasound probe tracked the 3D position and orientation of the 
individual 2D TRUS images acquired during the rotational sweep, yielding a transformation of 
every 2D TRUS image to a common 3D world coordinate system.  The 7 3D images indicated by 
probe positions in Figure 4.1 were acquired from 29 patients, for a total of 203 3D TRUS 
images.  During registration, surrogate intra-procedural images were extracted from the 3D 
TRUS images acquired at the bilateral sextant probe positions that simulated different 3D TRUS-
guided biopsy scenarios while the 3D TRUS image acquired at the baseline probe position 
served as the pre-procedural image.   
4.2.2 Image registration 
For all registrations, the 3D TRUS image at the baseline position (𝐼𝐵) was used as the moving 
image to update the target locations in the baseline image to compensate for motion. We used 
several different fixed image configurations, ranging from a single 2D TRUS plane to a full 3D 
TRUS image; Figure 4.2 lists the notations for the fixed image configurations used in the 
registration experiments in this paper, along with a schematic description of each.  The fixed 
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images extracted from 3D TRUS images at sextant probe positions are denoted as 𝐼𝛼1,𝛼2,…,𝛼𝑛, 
where 𝑛 is the number of planes extracted from angles 𝛼, or 𝐼𝛼1−𝛼2 for all planes between angles 
𝛼1 and 𝛼2; 𝛼 = 0 denotes the transverse or axial plane.  Thus, at one end of a continuum, 𝐼0 
indicates the use of a single transverse 2D TRUS image as the fixed image, and at the other end, 
𝐼0−179 indicates the full 3D TRUS image.  Extracting different planes from the 3D TRUS image 
to construct the fixed image (illustrated in Figure 4.2) simulates intra-procedural images for 
different intra-procedural scenarios, ranging from monoplanar 2D TRUS imaging [5, 11], 
through multi-planar and partial volume imaging [2], to full 3D TRUS imaging [1] conducted 
throughout the procedure. 
 
 
 
Figure 4.2: Fixed image configurations used in this paper: notation and schematics of planes from a probe-axis 
view. 
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Figure 4.3: Overall workflow in methods and validation. 
For each fixed image configuration given in Figure 4.2, registration and validation were 
performed according to the overall workflow given in Figure 4.3.  During image-based 
registration, the transformation from the mechanical tracker initialized the subsequent rigid 
registration performed by optimizing the normalized cross-correlation [19] (NCC) using 
Powell’s method [20] as the optimizer, as described in De Silva et al. [11]. A total of 174 
registrations were performed on images of 29 patients (6 registrations per patient) for each 
construction of fixed images according to Figure 4.2. For each patient 𝑖 = 1...29 and fixed image 
constructions with different probe positions 𝑗 = 1...6 we optimized the objective function given 
by normalized cross-correlation as 
𝑇𝑖𝑗  =   𝑟𝑔max
𝑖,𝑗
𝑁𝐶𝐶(𝐼𝛼1,..,𝛼2
𝑖𝑗 , 𝐼𝐵
𝑖 ; ?̌?𝑖𝑗) 
to determine the rigid transformation 𝑇𝑖𝑗 corresponding to the motion. 
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4.2.3 Registration error measurement 
Although the patient was in the lateral decubitus position during 3D TRUS image acquisitions, 
patient discomfort and TRUS probe pressure can cause prostate motion. Therefore, the 
ultrasound probe tracking information cannot be used to determine the motion of the prostate, 
since the prostate may have moved relative to the probe.  This motion was quantified relative to 
manually identified intrinsic fiducials (micro-calcifications) of the prostate.  Registration error 
was measured as the root mean square (RMS) target registration error (TRE) [21, 22] of 
manually identified corresponding pairs of fiducials for every registered 3D TRUS image pair.  It 
is important to note that the fiducial pairs were identified only to measure the accuracy of 
registration and were not provided as input to the registration algorithm.  Fiducials were 
identified throughout the 3D TRUS images regardless of the planes used for registration and the 
𝑘th fiducial in the fixed image of the 𝑖th patient in the 𝑗th sextant position is denoted by 𝑓𝐹
𝑖𝑗𝑘
 and 
the fiducials in the moving image by 𝑓𝑀
𝑖𝑘. Using the transformation (𝑇𝛼1,..,𝛼𝑛
𝑖𝑗
) obtained from the 
registrations at each fixed image configuration, the RMS TRE was calculated as 
𝑇𝑅𝐸𝛼1,..,𝛼𝑛 =
√∑ (𝑓𝐹
𝑖𝑗𝑘
−𝑇𝛼1,..,𝛼𝑛
𝑖𝑗
(𝑓𝑀
𝑖𝑘))2𝑖,𝑗,𝑘
𝑁
. 
4.2.4 Experimental methods 
A total of 1003 fiducial pairs were identified across image pairs of all patients with a mean ± 
standard deviation (std) of 5.8 ± 1.2 fiducial pairs per registration.  Figure 4.4 shows the 
distribution of the identified fiducials projected to Anterior/Posterior (A-P), Left/Right (L-R) and 
Inferior/Superior (I-S) planes from the 3D space, with the prostate size normalized from 0 to 1 
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along each direction.  Figure 4.5 depicts the sample calcification pairs that were identified as the 
anatomical landmarks. 
 
Figure 4.4: Distribution of manually identified fiducials used for registration validation. Each fiducial is shown with 
its Anterior/Posterior (A/P), Left/Right (L/R) and Inferior/Superior (I/S) position within the normalized prostate in 
which the boundaries extend from 0 to 1 along each direction.   
4.2.5 TRE for different fixed image configurations 
The RMS ± std TRE was calculated for each registration using the fixed image configurations 
defined in Figure 4.2.  To provide context for interpretation of these results, the pre-registration 
error and the fiducial registration error (FRE) [21] were also calculated.  To compare the two 
extremes of fixed image information (2D versus full 3D), the distribution of TRE improvements 
(𝑇𝑅𝐸0
𝑖𝑗 − 𝑇𝑅𝐸0−179
𝑖𝑗
) were calculated when using a full 3D TRUS image as opposed to using a 
single 2D TRUS image for motion compensation. 
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Figure 4.5: Example of the identified fiducials for three pairs of images.  Arrows point to homologous fiducial pairs 
in each row.  Baseline images with the fiducials are shown in the left and the sextant images of the same patient with 
corresponding fiducials are shown in the right. 
4.2.6 TRE for base, mid-gland and apex regions 
The TRE distributions were analysed separately for mid, base and apex regions of the prostate to 
understand the benefit of using additional 3D image planes in each region.  The TRE for each 
probe position was calculated separately as 
𝑇𝑅𝐸𝑗𝛼1,..,𝛼𝑛 =
√∑ (𝑓𝐹
𝑖𝑗𝑘
−𝑇𝛼1,..,𝛼𝑛
𝑖𝑗
(𝑓𝑀
𝑖𝑘))2𝑖,𝑘
𝑁𝑗
. 
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To determine an optimal registration error against which to compare the TREs, we 
calculated the FRE resulting from the rigid transformation that optimally aligned the intrinsic 
fiducials.  The FRE was calculated by finding the optimal rigid transformation that yielded the 
least squared error for the fiducials in a given image pair as 
𝐹𝑅𝐸𝑖𝑗 = argmin
𝑇𝑖𝑗
√∑ (𝑓𝐹
𝑖𝑗𝑘
−𝑇𝑖𝑗(𝑓𝑀
𝑖𝑘))2𝑘
𝑁𝑘
. 
4.3 Results 
4.3.1 TRE for different fixed image configurations 
 
Figure 4.6: TRE histograms for registrations using different fixed images, with the RMS ± std TRE shown in the 
top left of each histogram.  To provide context for the TRE distributions, row 1, column 1 shows the error 
distribution prior to registration and row 2, column 1 shows the error distribution after optimal rigid registration 
using the fiducials (FRE).  
Figure 4.6 shows the RMS ± std TRE for registration using each fixed image configuration 
defined in Figure 4.2, along with the pre-registration error and the FRE and the histograms of 
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each distribution.  Since these TRE distributions were found to be not normally distributed by a 
one-sample Komogorov-Smirnov test (p > 0.05), for each pairing of fixed image configurations 
we tested the null hypothesis that the paired distributions have the same medians with the non-
parametric Wilcoxon signed rank test.  The null hypothesis was rejected for each pair of 
distributions (p < 0.006) except for the pair of distributions with fixed images as 𝐼0,45 and 𝐼0,135 
(p = 0.2).  The RMS TRE decreased monotonically with an increasing number of planes included 
in the fixed image configuration.  The lowest and least variable error was obtained when the 
fixed image was selected to be the full 3D image (𝐼0−179).  Figure 4.7 compares the parameters 
of the TRE distributions at different fixed image configurations as a box and whisker plot.  To 
directly compare the extremes of fixed image configurations, Figure 4.8 shows the histogram of 
distribution of TRE error reductions resulting from the use of a 3D fixed image configuration, 
compared to a 2D fixed image configuration, calculated as 𝑇𝑅𝐸0
𝑖𝑗 − 𝑇𝑅𝐸0−179
𝑖𝑗
.  Figure 4.9 
shows qualitative examples of the alignments provided by registration with different fixed image 
configurations, for three patients.  Mean execution times for registrations with single-plane, bi-
plane, partial-volume, and full 3D volume fixed image configurations are shown in Table 4.1.  
The time required increases with more intensity samples used for registration.  The times were 
measured using a graphics processing unit (GPU) accelerated implementation of the NCC 
calculation with NVIDIA GTX 580 (NVIDIA Corporation, Santa Clara, CA) GPU and an Intel 
Xeon 2.5 GHz processor (Intel Corporation, Santa Clara, CA). 
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Figure 4.7: Comparison of TRE distribution parameters for different fixed image configurations. 
 
Figure 4.8: Histogram of TRE differences between I0 and I0-179. 
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Figure 4.9: Corresponding transverse 2D planes from; (a) fixed image, (b)-(d) transformed moving image after 
registration using the fixed image configurations as indicated, (e) moving image before registration. 
Table 4.1: Mean execution times for registration with different fixed image configurations 
Fixed image configuration Mean execution time (s)* 
𝑻𝑹𝑬𝟎 1.8 
𝑻𝑹𝑬𝟎,𝟗𝟎 2.1 
𝑻𝑹𝑬𝟎−𝟗𝟎 8.0 
𝑻𝑹𝑬𝟎−𝟏𝟕𝟗 14.6 
*Using a GPU accelerated implementation for NCC calculation (NVIDIA GTX 580 GPU card and Intel Xeon 2.5 GHz processor)  
 
4.3.2 TRE for base, mid-gland and apex regions 
In Table 4.2, we present the average TRE values in base, mid and apex regions of the prostate as 
well as TRE separately for each sextant region for two fixed image configurations: single plane 
Reg. using I0 Reg. using I0,90 Reg. using I0-90 Before reg.Fixed Image
TRE = 0.9 mm TRE = 1.3 mm TRE = 3.4 mm TRE = 8.0 mm
TRE = 1.4 mm TRE = 3.9 mm TRE = 5.1 mm TRE = 5.8 mm
TRE = 2.8 mm TRE = 3.6 mm TRE = 3.8 mm TRE = 11.4 mm
(a) (b) (c) (d) (e)
  
127 
 
and full 3D TRUS image.  The error before registration as well as 𝑇𝑅𝐸0 using a single plane was 
higher in the base and apex regions of the prostate when compared with the mid-gland; for both 
distribution pairs, the non-parametric Wilcoxon signed rank test rejected the null hypothesis (p < 
0.001) that the paired distributions had the same median.  The observed motion during biopsy 
movements within the left gland of the prostate was significantly larger (Wilcoxon signed rank 
test, p < 0.001) than that of the right gland even though the order of left to right and right to left 
acquisitions were reversed for half of the patients during image acquisitions.  The additional 
improvement in TRE (𝑇𝑅𝐸0
𝑗 − 𝑇𝑅𝐸0−179
𝑗 ) when using full 3D information as opposed to using a 
single plane for registrations, was larger (Wilcoxon signed rank test, p < 0.07) in the base and 
apex regions when compared with the improvements obtained in the mid-gland.  However, at the 
95% confidence level (p = 0.05) there was no significant difference between base, apex regions 
and the mid-gland detected. 
Table 4.2: RMS ± std TREs for registrations at different sextant probe positions. 
Sextant position 
(𝒋) 
Before reg. 
(mm) 
FRE (mm) 𝑻𝑹𝑬𝟎
𝒋
 (mm) 𝑻𝑹𝑬𝟎−𝟏𝟕𝟗
𝒋
 (mm) 𝑻𝑹𝑬𝟎
𝒋
− 𝑻𝑹𝑬𝟎−𝟏𝟕𝟗
𝒋
 
(mm) 
Base 5.3 ±2.6  1.2 ± 0.6 3.4 ±1.8 1.7 ± 0.7 1.7 
 – Left base 4.6 ± 2.6 1.1 ± 0.5 2.8 ± 1.6 1.5 ± 0.6 1.3 
 – Right base 5.9 ± 2.4 1.4 ± 0.7 3.9 ± 1.8  1.9 ± 0.9 2.0 
Mid 4.1 ± 2.1 0.9 ± 0.4 2.2 ± 1.0 1.3 ± 0.5 0.9 
 – Left mid  3.0 ± 1.5 1.0 ± 0.4 1.6 ± 0.6 1.3 ± 0.5 0.3 
 – Right mid 5.0 ± 2.2 0.9 ± 0.3 2.7 ± 1.2 1.3 ± 0.5  1.4 
Apex 5.3 ± 2.2 1.2 ± 0.7 3.5 ± 1.9 1.9 ± 1.0 1.6 
 – Left apex 4.1 ± 1.5 1.4 ± 0.8 3.0 ± 1.4 2.1 ± 1.2 0.9 
 – Right apex 6.3 ± 2.4 1.2 ± 0.5 4.0 ± 2.3 1.7 ± 0.7 2.3 
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4.4 Discussion 
In this work, we compared the accuracy and robustness of prostate motion compensation during 
TRUS-guided biopsy when varying amounts of 3D image content are available in the live images 
used for guidance, ranging from 2D images such as would be acquired from a conventional 
monoplanar probe, through bi- and multi-planar images, to full 3D TRUS imaging.  The results 
could inform the selection of a suitable approach in a clinical setting considering the trade-offs in 
accuracy, time and hardware costs.  Although 3D information has aided the registration 
algorithm in converging robustly to more accurate solutions, image acquisition and registration 
requires more time when using such information, and probe costs may increase.  In previously 
published approaches for 3D TRUS-guided biopsy [1, 5, 11], additional intra-procedural images 
have been obtained using the probes with enhanced functionality (the system described in 
Baumann et al. [1] requires 0.5–5s per temporal frame of acquisition) or could potentially be 
obtained via the rotation of a tracked TRUS probe prior to each biopsy (the systems described in 
Xu et al. [5] and De Silva et al. [11] require ~10s for a full 3D TRUS acquisition).  Whereas the 
former approach allows for more convenient acquisition of multiplanar images, the latter 
approach permits the use of widely available conventional 2D TRUS probes in systems that 
provide 3D TRUS guidance (e.g., by retrofitting, as in [3]), lowering the cost barrier to entry into 
3D TRUS-guided biopsy and leveraging the physician’s investment in existing 2D ultrasound 
machines.  For example, Xu et al. [5] proposed a method of incorporating additional 3D 
information by selecting frames with the largest separation in translations and rotations in the 
out-of-plane directions using the probe’s tracking information from the set of live 2D TRUS 
frames prior to targeting.  This approach uses the natural motion of the handheld probe over a 
short time period prior to biopsy to acquire additional planes.  As another example, the 
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mechanical system in Bax et al. [3] permits acquisition of additional imaging planes via the 
rotation of the tracked TRUS probe.  This system provides mechanical stabilization of the probe 
(including optional mechanical locking of all joints, permitting only axial probe rotation), which 
in principle could result in reduced prostate motion during acquisition. 
The co-registration to compensate for prostate motion could be improved further by 
applying a subsequent non-rigid refinement after the rigid registration, thereby compensating for 
the prostate deformation caused by the variability in TRUS probe pressure.  However, this 
clinical application requires high-speed registration; the higher degrees-of-freedom of a non-rigid 
transformation render high-speed registration very challenging.  The FRE calculated using 
manually identified intrinsic fiducials yields the error after an optimal rigid registration.  The 
FRE provides information about the room for improvement that may be obtained from a non-
rigid registration, to shed light on the potential return on investment of effort in development of 
high-speed non-rigid image registration algorithms for this clinical procedure.  We calculated an 
overall RMS ± std FRE of 1.2 ± 0.6 mm, which indicates that an optimal rigid alignment could 
achieve a clinically desirable level of accuracy (i.e., < 2.5 mm RMS error [23]), possibly 
eliminating the need to implement a more time-consuming non-rigid registration algorithm.  Our 
results show that the TRE values approached the FRE when including 3D intra-procedural 
imaging during registration. Moreover, previous work [1, 22] suggests that non-rigid registration 
yielded RMS TRE improvements < 0.6 mm when using intra-procedural 3D TRUS images.  
Therefore, the use of intra-procedural 3D TRUS imaging with rigid registration seems to provide 
a larger incremental benefit than the use of non-rigid registration. 
The development of image registration methods to compensate for motion could have 
applications in other 3D guided diagnostic and therapeutic interventional procedures [24, 25].  
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Hungr et al. [25] describe a 3D ultrasound robotic prostate brachytherapy system that utilizes 
motion compensation algorithms previously validated for biopsy guidance. The limited 
anatomical context available in single-plane 2D intra-procedural images could challenge the 
accuracy of co-registration with 3D pre-procedural images in many other interventional 
applications.  Uneri et al. evaluated the effect of dual projection view angles on 3D-2D 
registration accuracy of CT and x-ray projection images for surgical guidance.  Zvonarev et al. 
[26] and Fallavollita et al. [27] described multiple 2D plane-3D registrations related to lung and 
prostate brachytherapy. The methods described in this paper could have relevance in developing 
and evaluating techniques to improve registration accuracy and robustness in such interventional 
applications requiring rapid, robust registration by acquiring intra-procedural 3D imaging 
efficiently, only when necessary. 
4.4.1 TRE for different fixed image configurations 
The TREs for bi-planar registrations shown in Figure 4.6 do not indicate substantial variability in 
accuracy for the different angles between the two planes tested for those three fixed image 
configurations (i.e., 𝐼0,45, 𝐼0,135, 𝐼0,90).  The acquisition of a partial volume up to the angle of 
rotation with a conventional tracked monoplanar probe may support more accurate motion 
compensation than acquiring a single additional plane.  Consequently, that approach could result 
in more robust registrations than with a probe that simultaneously acquires dual orthogonal 
planes, at the cost of extra time for rotational acquisitions. 
According to the 𝑇𝑅𝐸0 distribution in Figure 4.6, 63% of the registrations have a TRE < 
2.5 mm when using a single 2D TRUS image as the fixed image configuration.  Figure 4.8 shows 
the histogram of distribution of TRE improvements calculated as 𝑇𝑅𝐸0
𝑖𝑗 − 𝑇𝑅𝐸0−179
𝑖𝑗
.  
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According to this distribution, the improvements were less than 1 mm in 56% of all registrations 
and were less than 2.5 mm in 87% of the registrations.  This suggests that although 3D 
information improved the accuracy and robustness of the registration, in the majority of the cases 
the error when using a single 2D TRUS plane was within a clinically acceptable range [23] or the 
improvements were not substantial when additional planes were included in the registration.  
Intra-procedural detection of misregistration by the operator could direct the efficient use of 3D 
image acquisition only for the subset of cases where this is beneficial. 
4.4.2 TRE for base, mid-gland and apex regions 
The analysis of TRE separately in the different sextant regions indicated that the base and apex 
regions were more challenging for the registration algorithm to compensate when only using a 
single 2D TRUS image, as compared with mid-gland regions.  The additional 3D TRUS 
information provided during registration was generally more beneficial in the base and apex 
regions, yielding higher comparative accuracy improvements as shown in Table 1.2.  When the 
TRUS probe is positioned near the edge of the gland at the base or apex, the resulting transverse 
2D views contain minimal prostate anatomy, which may not be sufficient to unambiguously co-
register with the pre-acquired baseline 3D TRUS image.  In order for the image-based 
registration to be successful in such challenging cases, it is reasonable to expect that the image 
content needs to capture richer contextual information, which can be achieved through oblique 
2D views or 3D partial volumes. 
4.4.3 Limitations 
The registration error (TRE) measurements in this paper were made using manually identified 
intrinsic fiducial landmarks within the prostate.  Therefore, the TRE measurements are limited 
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by the fiducial localization error (FLE) in 3D TRUS images, which were measured to be 0.21 
mm in a previous study [22] involving 3D TRUS images.  Fiducials were identified in baseline 
and sextant 3D TRUS images, irrespective of the planes used for registration in different fixed 
image configurations.  Therefore, when using fewer planes than the complete 3D TRUS image, 
the registration algorithm lacks complete information to calculate the optimal rigid transform for 
the identified fiducials.  While rigid motion of the prostate was assumed, any presence of non-
rigid motion would challenge the ability of the registration algorithm to reach the ground truth 
measured by the identified fiducials using fewer image planes.  FRE, calculated as the lowest 
possible error after applying a rigid transformation, is reflective of the magnitude of non-rigid 
deformation of the prostate.  Our results show that TRE approaches FRE when increasing the 
amount of intra-procedural 3D-TRUS image information during registration.  The remaining 
difference between the FRE and 𝑇𝑅𝐸0−179 could possibly be attributed to the FLE and the 
vulnerability of the registration optimizer in converging to local optima even when using full 3D 
TRUS images. 
The results presented in this paper are applicable to biopsy systems that utilize 3D 
guidance (e.g., Artemis [Eigen, Grass Valley, CA, USA], UroNav [In Vivo, USA], Urostation 
[Koelis, Grenoble, France], BiopSee [Pi Medical, Athens, Greece], Virtual Navigator [Esaote, 
Italy], Real-time Virtual Sonography [HI RVS] [Hitachi, Japan]).  Furthermore, in our study, the 
3D TRUS images were acquired using a manually rotated, tracked, and mechanically stabilized 
2D TRUS probe. 
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4.5 Conclusion 
In 3D TRUS-guided biopsy, accurate and rapid registration of live intra-procedural images to a 
pre-acquired 3D TRUS image is necessary to minimize targeting errors.  Intra-procedural 3D 
TRUS information supports robust convergence of the registration algorithm to more accurate 
solutions while compensating for motion.  Intra-procedural 3D TRUS information could be 
acquired either using probes with enhanced functionality (multi-planar or 3D probes) or by axial 
rotation of a tracked conventional 2D TRUS probe.  The acquisition of a partial volume up to the 
angle of rotation supported more accurate motion compensation than acquiring bi-plane 
configurations.  The results are helpful for devising mechanisms for motion compensation by 
taking advantage of intra-procedural 3D image acquisitions, considering the tradeoff of time, 
probe cost, and accuracy of motion compensation.  In 3D TRUS-guided biopsy systems, 3D 
intra-procedural image acquisitions help to achieve a robust registration that could improve the 
needle targeting accuracies to meet the clinical demands of such systems.  
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Chapter 5. 
Robust 2D-3D registration optimization to motion 
compensation using learned prostate motion data 
5.1 Introduction 
In this chapter, we describe and evaluate a 2D-3D TRUS registration that incorporates 
knowledge of prostate motion characteristics into the optimization process in order to improve 
registration accuracy and robustness. Although 3D intra-procedure image acquisitions could help 
to improve the robustness of the registration algorithm as described in the previous chapter, it is 
faster, more economical and less cumbersome to acquire live 2D TRUS images and to use them 
in registration for motion compensation during the procedure.  A robust 2D-3D registration 
algorithm would combine the advantages of more convenient live 2D TRUS acquisitions during 
the procedure with the improvements in motion compensation accuracy and robustness.  
Multiple algorithms have been proposed [1-4] to perform software-based motion compensation 
by registering intra-procedural TRUS images to an initially acquired 3D TRUS image. The 
system proposed in [3] used TRUS images acquired from a 3D TRUS probe to perform image-
based tracking to compensate for motion. Xu et al.[1] performed the registration after initializing 
several previous 2D TRUS frames in a 3D coordinate system using the transformations provided 
by a magnetically tracked probe. We previously [2] proposed a 2D-3D registration method using 
an initialization provided by a mechanically-tracked probe. The registration needs to be 
performed in a transformation space of, at minimum, 6 dimensions (for rigid registration), and 
the non-convexity of the objective function in the search space can drive the optimizer to local 
optima.  The methods in [1, 2] rely on some initialization mechanism and then optimize an 
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image-based, non-linear cost function using a local optimization technique whereas in [3] an 
initial global search mitigated local optima in the subsequent Powell-Brent search. While 2D-3D 
registration using a conventional real-time TRUS probe could be more challenging than 3D-3D 
registration [3] using a 3D TRUS probe, motion compensation with low inter-patient registration 
error variability and increased robustness is vital for successful clinical integration.  In this work, 
we investigated whether, in a 2D-3D registration problem, the learned characteristics of motion 
induced at different probe positions for prostates can be used to overcome local optima and drive 
the optimization to converge to the desired solution.   
Statistical representations of high-dimensional transformations have been used to learn 
prostate deformations to improve MR-TRUS registration [5, 6].  However,  statistical analyses 
have been previously performed using finite element analysis (FEA)-simulated motion in 3D 
TRUS images [5] and phantoms [6] whereas this work utilized statistics of observed motion in 
actual prostate interventions.  Outside of the prostate TRUS context, statistical representations of 
high-dimensional transformations have been previously used to learn or constrain both rigid and 
non-rigid registrations [7-9]. Strategies have also been proposed to improve the robustness of 
optimization techniques during registration [10].   
The objective of this work is to utilize the statistics of observed prostate motion data to 
improve the robustness of registration optimization.  In this work, we analysed the prostate 
motions observed from 29 patients to learn a model representing the characteristics of prostate 
motion. We then incorporated the parameters from this model to improve the robustness of the 
registration optimization.  The rest of the paper describes our approach to learning of prostate 
motion characteristics and our adaptation of that learned statistical information to improve the 
search for the optimum of the cost function. 
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5.2 Materials and Methods 
5.2.1 Data acquisition 
The images were acquired from 29 patients as part of a larger human subjects research ethics 
board approved MRI-3D TRUS fusion biopsy study of our institution. Using a mechanically-
assisted biopsy system described in Bax et al. [11], we acquired 3D TRUS images with an end-
firing 5-9 MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA) during human 
clinical biopsy procedures.  In addition to the baseline 3D TRUS image (𝐼𝐵: ℝ
3 → ℝ) that would 
usually be acquired following the standard operating procedure for the system in [11], we 
acquired six other 3D TRUS images (𝐼𝑃𝑖: ℝ
3 →  ℝ where 𝑖 ∈  {1,2, . .6}) after positioning the 
TRUS probe at the corresponding standard sextant systematic biopsy locations. Figure 5.1 shows 
the relative bilateral sextant probe positions in base, mid and apex regions of the prostate. The 
mechanical encoders attached to the TRUS probe tracked the 3D position and orientation of the 
probe in real-time, which enabled the transformation of 3D volume to a common world 
coordinate system. Images were acquired from 29 patients following the protocol described 
above with 7 3D TRUS images per patient, for 203 images in total. During 2D-3D registration a 
transverse 2D slice (𝐼𝑝𝑖: ℝ
3 → ℝ) was obtained from 3D TRUS images at each sextant probe 
position and registered to the baseline 3D image. 
  
140 
 
 
Figure 5.1: Probe positions during image acquisition shown relative to (a) coronal view (b) axial view. 
5.2.2 Modeling rigid prostate motion 
Corresponding fiducial pairs of anatomically homologous points (corresponding, naturally-
occurring micro-calcifications) were manually identified in 3D TRUS image pairs consisting of 
(𝐼𝐵, 𝐼𝑃𝑖) for each patient. We denote the fiducials identified in the baseline image as 𝑓𝐵  ∈ ℝ
3 and 
those identified in the image with probe position 𝑖 for that patient as 𝑓𝑃𝑖  ∈ ℝ
3. For each patient 
𝑗, we computed the optimal rigid alignment using the identified fiducials that defines the best six 
parameter rigid transformation vector 𝑥𝑖𝑗
∗  (henceforth referred to as a motion vector) out of all the 
possible rigid transformation vectors 𝑥𝑖𝑗 ∈ ℝ
6 according to, 
𝑥𝑖𝑗
∗ = arg min
𝑥𝑖𝑗
∑(𝑓𝑃𝑖
𝑚⨂ 𝑥𝑖𝑗 − 𝑓𝐵
𝑚⨂ yij)
2 
𝑀
𝑚=1
 
(
(5.1) 
where 𝑦𝑖𝑗: ℝ
3 → ℝ3 is the transformation obtained from tracking the probe (which maps the 3D 
image to the world coordinate system) and operator ⨂ denotes the application of a rigid 3D 
transform to the fiducial location.  𝑀 is the number of fiducial pairs identified per registration.  
Six such fiducial-based registrations per patient were performed, one for each sextant location. A 
total of 1003 fiducial pairs were identified with an average of 6 fiducial pairs per registration. It 
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is important to note that these fiducial pairs were identified only to measure and characterize 
prostate motion; the registration algorithm described in the following sections is fully image-
based and does not rely on the identification of fiducial landmarks. 
We analysed the estimated motion vectors to determine a suitable model to represent the 
observed data.  Each vector 𝑥𝑖𝑗
∗ , measured using manually identified fiducials, can be represented 
as a point in the six-dimensional (6D) rigid transformation space.  Different patient and probe 
positions generate a cloud of points in the 6D space representing the motions observed in the 
data set.  We assumed that prostate motion has some characteristic patterns, since the patient 
positioning constrains the motion in certain directions within the biopsy set-up and the 
transrectal access to the prostate constrains the motion of the TRUS probe during navigation.  
We analysed the distribution of the resulting point cloud in the 6D space to understand the 
patterns related to prostate movement during the biopsy procedure.  During our initial analysis, 
the point distribution failed an uni-modal Gaussianity test (Kolmogorov-Smirnov test, p < 
0.001).  Assuming the point distribution is multi-modal, we performed an unsupervised 
clustering of the data by fitting a mixture-of-Gaussians (MoG) model using expectation 
maximization (EM) algorithm [12].  The number of clusters is an important parameter that needs 
to be provided as input to the EM algorithm. We used the gap statistic [13] to calculate a 
reasonable estimate to this parameter.  We represented the estimated distribution of motion 
vectors as 
ℱ(𝑥) =  ∑𝒩(𝑥?̅?, 𝐶𝑡)
𝑇
𝑡=1
 
(
(5.2) 
where 𝑥?̅? is the mean of the cluster 𝑡 and 𝐶𝑡 is the covariance matrix of the Gaussian distribution 
𝑡.   
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5.2.3 Robust search strategy during registration optimization 
Equipped with a MoG model that represents prostate motion characteristics, we explored more 
effective ways to traverse the transformation space during registration optimization.  The class of 
optimization algorithms having the quadratic convergence property assume a quadratic model of 
the form 𝒢(𝑥) = 𝑥𝑇𝐴𝑥 + 2 𝑇𝑥 + 𝑐 in the local neighborhood of the optimum [14].  If this 
assumption is met within reasonable bounds, these algorithms can find the function optimum 
within a finite number of function and/or derivative evaluations.  This is a desirable property for 
registration problems requiring rapid convergence.  
To achieve quadratic convergence, some algorithms attempt to evaluate or approximate 
the Hessian matrix, 𝐴, in the quadratic model, 𝒢(𝑥), that captures the second order properties of 
the function [14].  Direction set methods like the conjugate gradient method [15] and Powell’s 
method [16] approximate a set of directions conjugate to 𝐴 without explicit knowledge of the 
function 𝒢(𝑥).   Improving (i.e., decreasing) the condition number of 𝐴 (the ratio between the 
largest and smallest eigenvalues of 𝐴) has been demonstrated to improve the convergence 
properties of such algorithms [17].  This approach scales the search space to increase the isotropy 
of a multi-dimensional objective function, which is helpful for the optimizer to take 
approximately equidistant steps during the line searches performed in a set of conjugate 
directions.  Figure 5.2 illustrates the effect of improving the condition number in a two-
dimensional hypothetical function with example line search direction shown in a red arrow from 
the starting location depicted by the red circle. 
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Figure 5.2: Diagram depicting the improvement (i.e., decrease) of the condition number (𝜆2/𝜆1) of a 2D objective 
function by scaling the search space according to the eigenvalues (𝜆2, 𝜆1) of the matrix 𝐴 of the objective function. 
(a) Initial search space of the objective function. (b) Situation after the search space is scaled according to 𝜆2, 𝜆1.  
Black ellipsoids/circles show the function iso-contours, with larger circles/ellipses indicating less optimal values of 
the objective function. The red circle shows an example initial search location and the red arrow shows a typical 
Powell’s method initial search direction. 
Powell’s method is a derivative-free optimization method that has quadratic convergence 
properties.  For a 𝐷-dimensional quadratic function, line minimizations along 𝐷 linearly 
independent, mutually conjugate directions will exactly find the function minimum. Powell's 
algorithm determines a set of such directions after initialization with the columns of any 𝐷 × 𝐷  
orthogonal matrix. For non-quadratic functions, which are usually encountered in image 
registration problems, repeated cycles of 𝐷 line searches are done iteratively until convergence. 
Usually this initialization is performed using the column vectors of an identity matrix [18]. 
𝐶𝑡 =  𝑈Λ
2𝑈  
(
(5.3) 
𝒩(𝑥?̅?, 𝐶𝑡)    = 𝑥?̅? +  𝒩(0, 𝐶𝑡) = 𝑥?̅? + 𝐶𝑡
1
2𝒩(0,1)  
= 𝑥?̅? + (𝑈Λ
2𝑈)
1
2𝒩(0,1) 
(
(5.4) 
λ2
x1
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𝑈 denotes the matrix containing the principal directions and Λ is the diagonal matrix containing 
the eigen values.  
Each cluster in the MoG model can be represented by its mean 𝑥𝑡 and covariance matrix 
𝐶𝑡.  The covariance matrix captures information related to the second order properties of the 
motion vector distribution in the 6D space within the cluster. The eigen decomposition of 𝐶𝑡 
yields an orthogonal matrix 𝑈 as shown in Equation 5.3 that contain the principal directions of 
maximal inter-patient variability of the observed motion vectors in the cluster 𝑡.  The eigenvalues 
of the matrix 𝑈 (contained in the diagonal elements in the matrix Λ) can be used to scale the 
search along corresponding principal directions contained in 𝑈.  Such an approach would scale 
the search space to improve the isotropic properties of the distribution of previously observed 
motion vectors in that cluster. Figure 5.3 illustrates how this scaling helps to guide the initial line 
searches towards the directions where we have already observed function optima. Thus, the 
principal directions given by the matrix 𝑈 after being appropriately scaled by its eigenvalues 
could provide a good initialization for the Powell’s direction set method. This is in principle 
different from the approach of scaling the search space to improve the condition number of the 
Hessian matrix, 𝐴 in that we do not explicitly learn properties related to 𝐴 for the functions in the 
observed data set.  We instead use the locations within the search space where the previous 
functions similar to 𝒢(𝑥) have converged.  We adopted this approach since we observed that 
characteristics of the Hessian matrices for different objective functions across the patients in the 
data set seem to be arbitrary, yet we were able to generate a model that represent the 
characteristics of the locations of the function optima. 
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Figure 5.3: Scaling the search space according to the eigen values (𝜆2, 𝜆1) of the covariance matrix 𝐶𝑡 of the 
observed motion vectors. (a) Initial distribution of the motion vectors in the search space. (b) After the search space 
is scaled according to 𝜆2, 𝜆1 in the principal directions.  The points representing the observed motion vectors (i.e., 
objective function optima). The red circle shows an example initial search location and the red arrow show a typical 
Powell’s method initial line search direction. 
We developed a two-stage search strategy with the objective of improving the robustness 
of registration optimization.  In order to mitigate the optimizer finding local optima, a multi-start 
search was devised as the first step.  The cluster means 𝑥𝑡 in the MoG model were used to 
initialize the multiple start positions in the search space.   Within each cluster, we optimized the 
normalized cross-correlation (NCC) image similarity metric using Powell’s direction set method.  
Powell’s method was initialized with the principal directions in the matrix 𝑈 obtained from eigen 
decomposition of 𝐶𝑡 as in Equation 5.3.  The search along these directions was scaled using the 
eigenvalues in Λ, by setting the step size proportional to those eigenvalues during the line 
direction searches.  This effectively scales the initial search directions such that the previously 
observed motion vectors are approximately isotropically distributed within the search space.  
During the second step of our search strategy, we selected the cluster that yielded best metric 
value after one iteration and continued the search until convergence.  While the rapid 
convergence property of Powell’s method is helpful in selecting the optimal cluster after a small 
(a) (b)
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x1
λ1
x2 x2
x1
λ2
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number of iterations, one iteration was empirically found to provide an accurate selection of the 
optimal cluster.   Thus, the search strategy adds only a finite number of extra line minimizations 
to the standard Powell’s method. 
5.2.4 Experiments 
For the 29 patients, we performed 174 registrations in total with 6 registrations per patient when 
the probe was positioned at each sextant biopsy location. We validated the registrations using the 
manually identified fiducials for each image pair and calculated the root mean square (RMS) 
target registration error (TRE).  We used leave-one-out cross-validation approach; fiducials in 
test image of a given patient were excluded in calculating the model and search directions for 
that patient. To compare the results, we performed registrations using Powell's method as in [2, 
18] henceforth  referred to as the initial method, and using the new version described in this 
paper and calculated the TREs separately for each method. 
5.3 Results 
Multiple trials evaluating the gap statistic yielded a mode of 4 as the number of clusters (𝑇) in 
our motion vector data.  Table 5.1 shows the RMS TREs and standard deviations (std) of errors 
before registration, after registration with the initial method, after registration with the new 
optimization method using the MoG model, and fiducial registration errors (FRE). The FRE 
calculated using the fiducials used during validation provides a lower bound on the TRE that can 
be obtained after performing a rigid registration.  Figure 5.4 shows distributions of TREs before 
and after registration with the two methods.  With the new optimization method, we observed a 
statistically significant difference in TRE (paired t-test rejected the null-hypothesis with p < 
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0.001) compared to the initial method indicating an improvement in accuracy and robustness of 
the registration. After using learned optimization method, the average number of iterations 
required for convergence decreased from 4.9 to 3.3. Using a GPU accelerated implementation for 
NCC calculation (NVIDIA GTX 580 GPU card and Intel Xeon 2.5 GHz processor), the updated 
method takes approximately an additional 1.1 s. However, multi-start strategy at different motion 
clusters can be executed in parallel to further reduce execution time during registration. Figure 
5.5 contains five representative example images, depicting the visual alignment qualitatively 
before and after registration with the methods described in the paper. 
Table 5.1: Comparisons of performance before and after registration with new and initial methods, and FRE. 
 Before Initial method New method FRE 
RMS TRE (mm) 4.95 3.12 2.33 1.15 
std (mm) 2.37 1.70 1.12 0.57 
Avg no of iterations n/a 4.9 3.3 n/a 
Execution time (s) n/a 1.7 2.8 n/a 
 
 
Figure 5.4: TRE histograms (a) TRE before registration. (b) TRE after registration without using learned prostate 
motion characteristics. (c) TRE after registration using the proposed method. 
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Figure 5.5: Images before and after registration for 5 patients. Top row: extracted 2D images (𝐼𝑝𝑖 ). Middle row: 
corresponding frames from the registered 𝐼𝐵. Bottom row: corresponding frames before registration obtained from 𝐼𝐵 
after tracking the probe.  
We analysed the robustness of the new method in comparison to the initial approach by 
evaluating the performance of the registration algorithms relative to the smallest clinically 
significant tumours, having a volume greater than 0.5 cm3 according to Epstein et al. [19].  To 
ensure the successful sampling of tumours with 5 mm radius, we examined cases that resulted 
with TRE >5 mm after the initial method to see how the accuracy has improved with the new 
method.  Table 5.2 compares the performance of that subset of registrations (TRE > 5mm with 
the initial method) with the two different methods. 
Table 5.2: Comparison of performance for registrations with TRE >5 mm with the initial approach. 
 Registrations with TRE > 5mm with the initial method  
 Mean  std Median Min Max  
TRE (initial) (mm) 6.70 1.71 5.96 5.00 10.84  
TRE (new) (mm) 3.25 1.39 2.77 1.54 6.30  
TRE(initial)-TRE (new) (mm) 3.45 2.49 2.69 -0.13 8.30  
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Figure 5.6: Comparisons of TREs in the two methods.  The gray circles indicate biopsies for which the TRE from 
the initial method was <= 5 mm. The coloured symbols indicate biopsies for which the TRE from the initial method 
was > 5 mm. The coloured squares indicate TREs from the initial method, and the coloured triangles indicate TREs 
from the new method.  Upward-pointing triangles show cases where the TRE from the new method was larger than 
the TRE from the initial method.  Downward-pointing triangles indicate cases where the TRE from the new method 
was smaller than the TRE from the initial method. A symbol of a given colour corresponds to a specific registration. 
With the initial method, the mean of all TREs > 5 mm was 6.7 mm.  With the new 
method, the mean TRE for these same patient cases was reduced to 3.25 mm; a reduction of 3.45 
mm. Figure 5.6 graphically illustrates the improvement in TRE given by the new method.  
According to this figure, we can see that in all but two cases the new method improved over the 
initial method, for cases where the initial method produced a TRE of > 5 mm.  We can also 
observe a shift of the gray circles in the downward direction with only a couple of circles lying 
above the 5 mm threshold line. 
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Figure 5.7: Comparison of NCC at convergence in the two methods. The gray circles indicate biopsies for which 
the TRE from the initial method was <= 5 mm. The coloured symbols indicate biopsies for which the TRE from the 
initial method was > 5 mm. The coloured squares indicate NCCs from the initial method, and the coloured triangles 
indicate NCCs from the new method.  Downward-pointing triangles show cases where the NCC from the new 
method was smaller than the NCC from the initial method.  Upward-pointing triangles indicate cases where the 
NCC from the new method was larger than the NCC from the initial method.  A symbol of a given colour 
corresponds to a specific registration. 
Figure 5.7 graphically illustrates the differences in NCC at convergence between the 
initial method and the new method. We observed that in all but one case the new approach to 
optimization based on learned motion data converged to a higher NCC than the initial method.  
We can also observe that the grey circles have an upward shift with the new method.  The 
improved NCCs at the time of convergence indicate that the optimizer has been successful in 
finding desired solutions in the objective function space. 
5.4 Discussion 
We observed an improvement in the 2D-3D registration performance after incorporating learned 
prostate motion characteristics into the algorithm.  Using the initial method, the 2D-3D 
registration had a TRE > 5 mm for nearly 10% (9.25%) of the biopsies in our sample. If 9.25% 
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of all biopsies are guided based using motion correction with TRE > 5 mm, then on average 
every patient undergoing 12-core extended extant biopsy will have one or more biopsies taken 
with sufficient motion correction error such that a tumour of clinically significant size may be 
missed.  Using the new method, the 2D-3D registration had a TRE > 5 mm for 1.16% of the 
biopsies in our sample. If 1.16% of all biopsies are guided based on using motion correction with 
TRE > 5 mm, then on average 1 out of every 86 biopsies will be taken with sufficient motion 
correction error such that a tumour of clinically significant size may be missed. Thus, on 
average, one out of every eight patients undergoing 12-core extended sextant biopsy will have 
one or more biopsies taken with sufficient motion correction error such that a tumour of 
clinically significant size may be missed. 
The calculation of the best rigid transformations (𝑥𝑖𝑗
∗ ) to characterize prostate motion is 
limited by the operator's ability to accurately identify and correspond fiducial locations. Since we 
considered the transformations given by the manually identified fiducials as the ground truth, 
fiducial localization error limits our ability to measure a registration algorithm’s in improvement 
of accuracy. Furthermore, any non-rigid deformation of the prostate would challenge our 
assumption of rigid motion. The ability of the registration to match the best rigid alignment 
calculated based on fiducials identified throughout the prostate could also be limited by the fact 
that we are restricted to using a single 2D slice during registration. In such a situation, non-rigid 
deformation might pose an additional challenge for the algorithm to estimate the overall rigid 
motion of the prostate by only using the image information in the 2D plane.  
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5.5 Conclusions 
In this paper, we demonstrated that the learned prostate motion directions can be used to improve 
2D-3D TRUS registration optimization, which has the potential to improve the clinical outcomes 
of MRI-3D TRUS fusion biopsy. Our results indicate that we can improve the accuracy and 
robustness of the algorithm, at the cost of 1-2 s of additional execution time.  This would help 3D 
TRUS-guided biopsy systems to achieve clinically desired level of accuracy in needle targeting. 
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Chapter 6. 
Conclusions and Directions for Future Work 
6.1 Conclusions 
The work in this thesis intends to improve needle targeting accuracy of 3D TRUS-guided 
biopsy systems.  Towards achieving this goal, the errors due to patient and prostate 
motion during the procedure were quantified and methods were developed to compensate 
for the intermittent motion via rapid image-based registration techniques.  The methods 
developed in this work have been successfully integrated into the mechanically assisted 
3D TRUS-guided biopsy system [1] previously developed in our lab and are currently 
being used in human clinical biopsy procedures as part of an ongoing study.  The work 
was divided into four chapters according to the objectives listed in the Section 1.9, and 
the conclusions of each are discussed in the following. 
In Chapter 2, we used non-rigid registration of 2D TRUS images to quantify the 
deformation that occurs during the needle insertion and the biopsy gun firing procedure 
and compared this effect in biopsies performed using a hand held TRUS probe with those 
performed using mechanically assisted 3D TRUS-guided biopsy system [1].  While such 
errors had been previously quantified in prostate brachytherapy applications where 
accurate needle guidance is necessary for radioactive seed implantations, we investigated 
this problem in the context of 3D TRUS-guided biopsy.  Prostate deformation during 
needle insertion can cause target misalignments after the physician has successfully 
aligned the biopsy needle trajectory with the target locations in preparation for taking a 
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tissue sample.  Since the needle insertion and biopsy gun firing happen in a rapid 
progression within a sub-second interval, the targeting error due to prostate deformation 
in that duration is very challenging to compensate.  However, given the need to 
accurately sample the smallest clinically significant tumours, it is an important 
consideration when setting the design specifications for MR-targeted TRUS-guided 
prostate biopsy systems.  As described in Section 1.10.2, an image registration algorithm 
with RMS TRE ≤ 2.3 mm is required for the central hypothesis of this work to be 
confirmed, in the context of our measured tissue displacement due to biopsy needle 
insertion.  
In Chapter 3, we described a technique to compensate for intermittent patient and 
prostate motion during biopsy, which is the central problem addressed in the work of this 
thesis.  Compared to the errors quantified in Chapter 2, patient motion due to discomfort 
and prostate motion due to applied TRUS probe pressure caused larger target 
misalignments, limiting needle targeting accuracy [2].  We developed an image-based 
2D-3D registration algorithm to align live 2D TRUS images acquired during the 
procedure with the baseline 3D TRUS image acquired immediately prior to performing 
biopsy.  The accuracy was measured by calculating the TRE using manually identified 
fiducials (micro-calcifications) of the prostate.  A GPU-based implementation was used 
to improve the registration speed.  While this showed encouraging results by achieving 
statistically significant improvements in accuracy, there were some registrations with 
error >5 mm and a measured RMS TRE of 3.2 mm.  Therefore, methods to improve the 
accuracy and robustness of this technique would be helpful to meet the clinical 
requirements. 
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In Chapter 4, we evaluated the utility of incorporating additional intra-procedural 
3D TRUS image information in guiding registration for improved motion compensation.  
The limited anatomical context available in a subset of the live 2D TRUS images might 
not capture sufficient information to obtain an accurate registration with the baseline 3D 
TRUS image.  While 2D TRUS images are widely used for intra-procedural guidance, 
some solutions utilize richer intra-procedural images such as bi- or multi-planar TRUS or 
3D TRUS, acquired by specialized probes.  Therefore, the impact of such richer intra-
procedural imaging on displacement compensation accuracy was measured to evaluate 
the tradeoff between cost and complexity of intra-procedural imaging versus improved 
displacement compensation.  We performed an extensive validation using baseline and 
intra-procedural 3D TRUS images acquired from 29 patients.  While the majority of the 
registrations using 2D TRUS images provided a clinically desired level of accuracy, 
intra-procedural 3D imaging helped improve the overall registration accuracy and 
robustness, especially in the base and apex regions of the prostate.  These results are 
helpful for devising image-based registration methods and designing clinical workflow 
for motion compensation in 3D TRUS-guided biopsy systems. 
Towards the objective of improving the robustness of registration for motion 
compensation, we investigated an alternative approach in Chapter 5 that does not require 
additional image acquisitions during the procedure.  Since the patient motion is 
constrained while being in the left lateral decubitus positioning within the biopsy setup 
and the TRUS probe motion is restricted while accessing the prostate transrectally, it is 
reasonable to assume that prostate motion has some characteristic patterns.  Incorporating 
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information of the identified characteristic patterns of prostate motion during registration 
optimization helped to improve the robustness in an effective manner.   
In this thesis, we have demonstrated the use of image-based registration methods 
to quantify and compensate for prostate motion during 3D TRUS-guided biopsy.  
According to our hypothesis, the RMS error of the biopsy systems should be ≤ 2.5 mm in 
order to accurately sample the smallest clinically significant tumours.  The errors due to 
prostate deformation during needle insertion and biopsy-gun firing restrict this 
requirement further to 2.3 mm.  Although 2D-3D registration methods described in 
Chapter 3 were encouraging, with statistically significant improvements in compensating 
for intermittent patient and prostate motion, methods to further improve accuracy and 
robustness were needed for the successful clinical translation of this technique.  Chapter 4 
and 5 describe two different approaches to achieving improved registration accuracies.  
The improved accuracy and robustness either by acquiring intra-procedure 3D image 
information for use during registration or by improving the registration optimization 
using the learned motion characteristics of the prostate have demonstrated performance 
improvements in image-based registration that meet the clinical requirements for needle 
targeting accuracy of the biopsy system.   
Thus, the central hypothesis of this thesis is confirmed when either of the 
approaches described in Chapters 4 or 5 are applied, and the choice of approach to use in 
a given context may be guided by ultrasound probe/machine availability.  The central 
hypothesis of this thesis is not confirmed when only the approach described in Chapter 3 
is applied. 
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6.2 Suggestions for future work 
The registration techniques developed in this work could be directly helpful in ongoing 
clinical investigations related to prostate biopsy.  There are other clinical applications that 
require rapid registration to transform pre-procedure image information to the intra-
procedure image space to improve diagnostic and therapeutic clinical outcomes in image-
guided interventions. Some extensions of the work described in this thesis might lead to 
applications in multiple such areas of currently active research. 
6.2.1 Applications in ongoing clinical studies 
Multiple clinical studies [3-5] have reported improved cancer detection rates using MR-
targeted biopsy schemes.  It would be interesting to investigate how the improved needle 
targeting accuracy after integrating prostate motion compensation into the clinical 
workflow during the procedure impact clinical outcomes of the procedure.  The potential 
impact in cancer detection rates could be investigated in a prospective clinical study.  The 
improved cancer detection rates could elevate the ability of the physician to better 
differentiate between clinically aggressive and indolent tumours by strengthening the 
confidence of the evidence.   During prostate cancer diagnosis and patient risk 
stratification, however, the current standards of interpreting biopsy results are calibrated 
to the conventional random systematic biopsy schemes, which carry a higher degree of 
uncertainty.  The ability to accurately target suspicions foci might lead to re-visit the 
current guidelines to improve the interpretation of biopsy results with more reliable 
evidence of the disease at hand. 
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6.2.2 Applications in other clinical procedures 
The techniques developed in this thesis could have relevance in other image-guided 
interventions that require fast and accurate registration to compensate for organ motion.  
One such example with direct relevance to prostate cancer management is in emerging [6, 
7] interventional systems developed to treat intermediate-risk prostate cancer with 
localized ablation.  In such systems, tumours contoured prior to the procedure need to be 
detected and verified in the intra-procedure images prior to ablation.  Motion correction 
algorithms could be helpful to align the target regions during the procedure to improve 
the accuracy of ablating the intended region and to ultimately reduce the margins ablated 
around the tumour due to uncertainty.  Prostate deformation could be a potential 
challenge in developing such registration algorithms for some applications.  For example, 
during focal laser ablation [6] of tumours, intra-procedure MR images are acquired to 
verify the target region.  The endorectal coil used to acquire MR images could deform the 
prostate differently than when it was acquired prior to the procedure for diagnostic 
purposes.  Non-rigid registration algorithms might be necessary to account for such 
differences in deformation during the procedure after achieving a robust rigid registration 
as an initial step.  The techniques described in this work needs to be extended to account 
for non-rigid deformations in such applications.   
Ultrasound-guided interventional systems have recently been developed for tissue 
ablation in kidney [8] and liver [9].  Organ motion during the procedure could limit their 
accuracy in delivering the treatment to the desired region.  Hence, these systems might 
also potentially benefit from rapid image registration algorithms to compensate for organ 
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motion.  However, the characteristics of motion in the organ of interest are an important 
consideration when developing registration techniques.  The liver motion, for example, 
could be affected primarily by the periodic breathing, since it is an organ with close 
anatomical proximity to the lung.  When compensating for such continuous and periodic 
motion, the registration might need to be performed faster than what was required during 
prostate biopsy.  Efficient software code optimization and parallel implementations could 
help to further improve registration times. 
6.2.3 Applications in image-based tracking  
Intra-procedure image tracking is an essential component when developing systems to 
perform many image-guided interventions.  Electromagnetic, optical and mechanical 
devices are typically used to track real-time imaging devices during the procedures.  Pure 
image-based tracking is an alternative method that can be used to determine the position 
and the orientation of the imaging device via image registration.  Low cost and compact 
design are the major advantages of this approach by eliminating the need for hardware 
tracking devices in the system.  In the experiments described in this thesis, we used the 
transformation given by the mechanical tracking device to initialize the registrations.  If 
the registration is performed without this initialization, it has to simultaneously 
compensate for motion of the prostate as well as the motion of the TRUS probe.  This 
would be a very challenging correspondence problem considering the limited information 
available in a single plane 2D TRUS image.  If the prior knowledge of the prostate 
anatomy and the prostate motion can be used to provide a reasonable initialization to the 
registration algorithm, that could help to make the registration problem more tractable 
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when only using the image information.   Technical advancements in methodology for 
incorporating prior domain knowledge into the registration framework might help to 
achieve accurate and robust results that would benefit the development of software-based 
solutions and their widespread use for tracking purposes.  
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